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SUMMARY
Although adrenaline has been reported to lower intraocular 
pressure (lOP) in both the conscious and anaesthetised rabbit 
the mechanism and adrenoceptor(s ) involved in this hypotensive 
response are unclear.
In the conscious rabbit topically applied adrenaline 
produced a biphasic pressure response, an initial hypertensive 
response followed by the expected but longer lasting hypotensive 
response. Adrenaline also produced mydriasis, an alpha 
adrenoceptor mediated response.
The mechanism whereby adrenaline lowers lOP was 
investigated by measuring the facility of outflow of aqueous 
humour from the anterior chamber of the anaesthetised rabbit 
using a constant pressure anterior chamber perfusion technique. 
Topically applied adrenaline raised facility of outflow and 
lowered lOP. Adrenaline produced its expected mydriasis.
To date the majority of evidence suggest that adrenaline 
lowers lOP by acting via a beta adrenoceptor. Timolol was used 
as a pharmacological tool in the present experiments to 
investigate the involvement of the beta adrenoceptor in the 
outflow response to adrenaline. Timolol largely reversed the 
outflow response to adrenaline.
All of the afore mentioned results imply that adrenaline 
lowers I OP by raising facility of outflow, an effect mediated 
via a beta adrenoceptor since it was reversed by timolol.
Indomethacin, an inhibitor of prostaglandin (PG), 
biosynthesis can antagonise the ocular hypotensive response to 
chronic adrenaline treatment in the conscious rabbit. In the 
present experiments topical indomethacin pretreatment markedly 
antagonised the rise in facility of outflow and resultant fall
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in lOP caused by acute topical adrenaline treatment in the 
anaesthetised and conscious rabbit. This result suggested that 
following the interaction with beta adrenoceptors, PGs were 
involved at some stage in the outflow and pressure responses to 
adrenaline.
Since indomethacin has known calcium antagonistic
properties, the effects of aspirin and piroxicam, whose
subsidiary properties differ from those of indomethacin, on the 
outflow and pressure responses to adrenaline were investigated.
Systemic aspirin pretreatment had no affect on the ocular 
responses to adrenaline or their antagonism by indomethacin in
the anaesthetised rabbit. The lack of an inhibitory effect by
aspirin, be it through inhibition of PG. biosynthesis, or 
calcium antagonism, was perhaps explained by the comparitively 
low plasma levels of salicylic acid. Alternatively, the ability 
of aspirin to inhibit ocular biosynthesis may differ from that 
in other organs.
Piroxicam is a potent inhibitor of PG biosynthesis at 
concentrations which have no effect on calcium fluxes. Topical 
piroxicam pretreatment antagonised the adrenaline-induced rise 
in facility of outflow and fall in I OP in the anaesthetised 
rabbit. This result lends weight to the theory that
indomethacin antagonises the outflow response to adrenaline by 
blocking PG synthesis and not by inhibiting calcium movements. 
Nonetheless the effects of verapamil, a calcium channel blocker, 
on the pressure responses to adrenaline were investigated. 
Although topical verapamil pretreatment partially inhibited the 
hypertensive response (which may be the result of extraocular 
muscle contraction) to adrenaline the hypotensive response was 
unaltered. Again this result strengthens the hypothesis that 
adrenaline interacts on the beta adrenoceptor which at some
xiv
stage results in the production of PGs which in turn could be 
responsible for the rise in facilty of outflow and consequent 
fall in lOP. This is also consistent with other workers' 
demonstration that low concentrations of PGs can both raise 
facility of outflow and lower lOP.
Measuring PG concentrations in the aqueous humour was a 
more direct way of investigating the possible involevement of 
PGs in the ocular response to adrenaline. In the present 
experiments PG concentrations in the aqueous humour were 
measured using radioimmunoussay. Unfortunately this assay could 
neither accurately measure the very low concentrations of PGs 
present in aqueous humour samples nor distinguish differences in 
PG concentrations before and after drug treatment.
Beta adrenoceptor stimulation usually results in the 
production of cAMP. cAMP can both raise facility of outflow and 
lower IOP in the rabbit and many workers believe that it is this 
cAMP which is responsible for the ocular responses to 
adrenaline. Since indomethacin was reported to antagonise the 
outflow response to intracamerally injected cAMP one might 
postulate that cAMP triggers PG synthesis. Therefore in these 
experiments the effect of piroxicam and indomethacin 
pretreatment on the ocular reponses to intracamerally injected 
cAMP were investigated. Control experiments were also carried 
out. However the technical problems associated with the 
prolonged presence of 2 perfusion needles and/or the injection 
of substances into the anterior chamber precluded any 
conclusions being drawn from these experiments.
The relevance of this work to the human eye has recently 
been confirmed by a report showing that systemic indomethacin 
reduces the hypotensive response to chronic adrenaline treatment 
in glaucoma patients.
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INTRODOCTIOH
The Anatomy Of Ttie Formation And Drainage Of Aqueous 
Humour.
Aqueous humour (AH) is a colourless fluid present in 
both the posterior and anterior chambers of the eye. The 
main functions of AH are two fold, firstly for the supply of 
nutrients to and the removal of waste products from the 
avascular portions of the eye, namely the lens and the
cornea. Secondly, it serves a hydromechanical function
providing stability to ocular dimensions and the internal
structures associated with performance of visual function.
AH is formed continuously in the posterior chamber by 
the ciliary processes. The newly formed AH flows from the 
posterior chamber into the anterior chamber via the pupil. 
It then flows from the anterior chamber into the outflow 
system. In rabbits the outflow of AH occurs primarily at 
the iridocorneal angle where it flows through the trabecular 
meshwork into the angular aqueous plexus and finally into 
the venous system.
The formation of aqneoos himoiir.
AH is formed by the ciliary processes in the anterior 
chamber. A partial filtrate of plasma forms in the stroma
of the ciliary processes from the capillaries which supply 
it. This constitutes the fluid from which the ciliary 
processes form AH by two main processes, secretion and 
ultrafiltration, of which secretion is the most important .
Secretion.
The ciliary processes have an epithelium which consists 
of a double layer of cells, a pigmented and a non-pigmented 
epithelium. The inner layer, the non-pigmented epithelium 
(NPE), lies next to the AH while the outer heavily pigmented 
epithelium (PE) lies closer to the stroma.
Cole (1977) has postulated that the sodium ion is 
absorbed from the ciliary stroma by the NPE and then 
transported into the intracellular clefts of the ciliary 
epithelium. This influx of sodium into the anterior chamber 
is inhibited by a variety of compounds including ouabain and 
dinitrophenol, indicating the existence of a transport 
system which actively transports sodium across the ciliary 
epithelium.
The inhibition of sodium transport by the cardiac 
glycosides is related to the inhibition of a 
sodium-potassium ATPase. This enzyme has been localised 
mainly at the cell surface and the multiple infoldings which 
bound the intercellular channels of the NPE.
The active transport of solute into the lateral 
intercellular spaces between epithelial cells makes the 
channel fluid hypertonic. Water therefore enters the 
intracellular spaces and in the steady state a standing 
osmotic gradient is created. Since the intracellular clefts 
of the ciliary epithelium are closed at the stromal side by 
tight junctions, but are open at the posterior chamber side, 
fluid therefore tends to flow towards the posterior chamber.
The active transport of sodium into the intracellular clefts 
creates an electrochemical gradient which favours the
movement of anions, in this case chloride ions, in the same 
direction as the sodium ions.
Since treatment with cardiac glycosides or
dinitrophenol reduces sodium influx by only 50% this implies 
that sodium is transported across the ciliary epithelium by 
some other means. Some movement of the sodium ions could be 
linked with the active transport of anions such as chloride 
or bicarbonate ions.
Holland and Gibson (1970) have shown that part of the 
net flux of chloride ions into the intracellular clefts can 
be attributed to the active transport of this ion. The
active transport of the chloride ion could explain why the 
ciliary epithelial surface is electronegative relative to 
the stromal surface. The in vitro active chloride transport 
in cat ciliary processes also correlated well with the
chemically demonstrated excess of chloride in the AH 
(Holland and Stockwell, 1967; Holland and Gibson, 1970). 
Sodium ions may therefore move passively down an 
electrochemical gradient as a result of active chloride 
transport.
In 1973, Maren showed that acetazolamide lowered sodium 
and bicarbonate concentrations in the posterior chamber of 
the dog. Acetazolamide also lowers intraocular pressure and 
reduces the rate of production of AH (Becker and Constant, 
1955; Garg and Oppel, 1970). In view of acetazolamide ' s 
well known inhibition of carbonic anhydrase, it is 
reasonable to suppose that bicarbonate is actively 
transported from the ciliary epithelium and partly coupled 
to this is the influx of sodium into the posterior chamber.
3
ultrafiltration
Ultrafiltration is a pressure-dependent process which 
relies on the presence of "leaky" junctions, i.e. one which 
has a relatively high passive permeability to ions. Values 
for resistance transport potential and osmolarity ratio of 
the ciliary processes place the junctions between the apices 
of the PE and NPE within the catergory of leaky junctions 
(Cole, 1966, Pederson and Green, 1973).
The balance of hydrostatic, oncotic and osmotic 
pressures across the apical complex of the NPE determine the 
relative proportion of ultrafiltration and secretion.
Some workers believe that ultrafiltration plays a major 
role in the formation of AH (Green and Pederson 1972, 
Weinbaum, 1972; Pederson and Green 1973); on the other hand 
Bill (1975) has shown that hydrostatic pressure and 
oncotic pressure differences across the ciliary processes do 
not support the likelihood of ultrafiltration normally 
occurring.
The chemical composition of AH
The composition of the AH has been investigated by 
Kinsey and Reddy (1964) and Bito (1977). In general its 
composition resembles that of extracellular fluid of 
peripheral tissues, but with differences between freshly 
secreted AH and AH in the anterior chamber.
Junctions between the NPE cells are tight enough to 
prevent the passage of macromolecular markers. Peroxidase 
can enter the ciliary stroma following intravenous injection 
and penetrate between the PE cells, but it then accumulates 
at the apices of the NPE layer (Cole, 1977). These cells 
therefore constitute the "blood aqueous barrier" which is
responsible for greatly limiting the amount of plasma 
protein which can accompany fluid secreted into the 
posterior chamber. Therefore, the greatest difference 
between AH and blood plasma lies in the protein 
concentration which are 0.02 - 0.06% and 6-7% respectively.
The sodium and potassium contents of the anterior
chamber AH are essentially the same as those of the plasma. 
The chloride ion content of the posterior chamber AH is 
lower than that of plasma but rises somewhat as the fluid 
passes through the anterior chamber. This chloride
deficiency is balanced by an excess of bicarbonate ions 
present in the anterior and posterior AH as compared to 
levels of bicarbonate in the plasma.
The ascorbic acid concentration of both anterior and 
posterior chamber AH is many times higher than plasma
levels. In contrast, as a result of glucose utilization by 
the avascular cornea and lens, glucose levels are 10 to 20% 
lower than in plasma levels.
Unlike most species, rabbit AH has higher
concentrations of amino acids compared to plasma.
The pH of both anterior and posterior AH is at least 
0.2 units greater than that of plasma.
The drainage of AH
In primates and rabbits AH drains from the eye 
primarily through the "conventional" passageway although 
some may leave the eye through other less important pathways 
(refer to Figs A and B throughout this section).
Conventional Outflow route
In rabbits the conventional drainage pathway consists 
of the trabecular meshwork, the angular aqueous plexus and 
the intra- and episcleral plexus of collecting channels, 
including the aqueous veins. Although the rabbit differs 
from primates in certain aspects of the anatomy and 
morphology of the anterior chamber angle, namely the angular 
aqueous plexus (as opposed to its equivalent in primates, 
the Canal of Schlemm), an insubstantial ciliary muscle and 
the absence of a scleral spur, the physiological 
similarities have often been stressed.
The poorly developed ciliary muscle in the rabbit 
results in a posterior extension of the anterior chamber, as 
well as the major bulk of the ciliary body being loose 
connective tissue which consists of several layers of 
adventitial cells, occasional smooth muscle cells, 
melanocytes, scattered collagen fibrils, clumps of 
elastin-like material and other extracellular components. 
In the rabbit the patency of the ciliary cleft and drainage 
angle cannot be maintained by the ciliary muscle, but is
jt
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instead supported by several connective tissue strands, now 
commonly referred to as the iris processes. These processes 
originate from the iris and proceed anteriorly towards the 
cornea where they merge with the corneal endothelium and its 
membrane (Descemet's membrane).
The spaces delineated by these processes are called the 
spaces of Fontana (Tripathi, 1971, 1974) and serve as
passage ways for the flow of AH into the depth of the 
ciliary cleft.
Having entered the ciliary cleft the AH then flows 
through the trabecular meshwork. In general the trabecular 
meshwork consists of a series of endothelium-covered 
collagenous cords and fibrocellular perforated sheets 
(trabeculae). The endothelial lining of the trabeculae is a 
continuation of the corneal endothelium and Descemet's 
layer. The trabeculae are rarely fully encased by this 
endothelial layer (Grierson, 1976).
In rabbits, the cilary cleft is shallower but more 
highly developed than in primates (Prince, 1964). Although 
these differences do occur, the rabbit has layers of 
trabeculae with connections corresponding directly with a 
uveal and corneoscleral connection in addition to an 
endothelial meshwork close to the angular aqueous plexus.
Uveal meshwork.
This lies closest to the chamber angle and has a 
distinctive outer and inner layer.
The outer trabeculae are orientated circumferentially, 
parallel to the surface of the cornea at the limbus and are 
flattened perforated sheets.
The inner layers are cord like and are orientated 
radially in a net-like fashion enclosing large oval spaces. 
This layer therefore offers little resistance to the outflow 
of AH.
Corneoscleral meshwork.
This adjoins the uveal meshwork and is morphologically 
very similar to the outer uveal trabeculae, but has 
narrower inter - trabecular spaces. These are also 
orientated circumferentially. In rabbits there are fewer 
layers of corneoscleral trabeculae than in primates. 
(Tripathi, 1974).
Endothelial meshwork.
Close to each aqueous vessel of the angular aqueous 
plexus is a narrow zone where endothelial cells form a 
network. This is termed the endothelial meshwork. It lacks 
trabecular cores and the endothelial cells are surrounded by 
amorphous and fibrillar material which is probably dispersed 
in a mucopolysaccharide matrix.
The trabecular meshwork as a whole, therefore forms a 
labyrinth of intercommunicating intra- and inter 
trabecular spaces of variable sizes and shapes and this may
be likened to a coarse filter whose porosity is probably 
influenced by biochemical agents acting directly on the
meshwork or indirectly through the ciliary muscle (and, 
therefore, to a lesser extent in rabbits).
Prior to its entry into the angular aqueous plexus, 
insoluble material may be removed from the AH not only by
the sieve-like action of the meshwork but also by its
endothelial cells which can phagocytose and degrade debris 
which enters (Tripathi 1971, and Tripathi, 1972 and Tripathi 
Tripathi, 1977).
The majority of resistance to flow of AH is believed to 
reside in the inner trabecular meshwork and/or the inner
walls of the angular aqueous plexus.
This resistance is believed to be a result of a 
mucinous coating, probably present on the surface of the 
endothelial cells of trabeculae and angular aqueous plexus 
(Tripathi, 1971, Tripathi, and Tripathi, 1972 and Tripathi, 
1977) and perhaps the basement membrane material of the
trabecular meshwork. (Armaly and Wang, 1975; Grierson and 
Lee, 1975a; Tripathi, 1974). This mucin coating probably 
consists of glycosaminoglycans (Mizokami, 1977, 
Schachtschabel, 1977). The origin of this coating is 
unclear, but it may be produced by the endothelial cells
(Berggren and Vrabec, 1957). The heaviest concentrations of
mucopolysaccharides are found in the extracellular spaces of 
the endothelial meshwork in the rabbit (Grierson, 1976).
Due to its physical presence or to its charge, such a 
coating may reduce the effective open area for aqueous
humour percolation, thereby offering resistance to flow.
In rabbits AH drains from the trabecular meshwork into 
a series of drainage channels, called the angular aqueous
plexus (AAP) (Tripathi, 1971,1974). These are equivalent to 
the canal of Schlemm in primates.
The vessels of the AAP have a continuous endothelial 
lining whose ultrastructural characteristics are similar to 
those in the inner wall endothelium lining of the canal of 
Schlemm. The channels themselves have a morphology similar 
to Schlemm's canal.
A few reports have described the presence of smooth 
muscle cells in the structural elements associated with the 
AAP'in rabbits. (Knepper et ^ .  , 1975, Sakimoto, 1979).
They were most frequently observed in the corneoscleral 
tissue neighbouring trabecular meshwork and less frequently 
in the limbal region of the cornea and in the sclera 
external to the ciliary muscle cells. The cells were 
usually located on one side of the channel, but occasionally 
they completely surrounded the channel. Sakimoto believes 
that contraction of these smooth muscle cells may regulate 
AH outflow in the rabbit eye.
The means by which AH enters the AAP from the 
trabecular meshwork is a subject of great discussion. The 
view held by many workers is that transcellular channel 
formation is the main process involved (Tripathi, 19 71b; 
Inomata, Bill and Smelser, 1972, Grierson, 1976). In this 
process indentations of the basal aspect of Schlemm's canal 
from the trabecular meshwork side results in the formation 
of a vacuole. This vacuole gradually enlarges and 
eventually opens on the apical aspect of the cell to form a 
transcellular channel. After a certain time interval the 
basal infolding is occluded by cell cytoplasm and the cell 
returns to its non-vacuolated stage. Ihe initial
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indentation of the cell may result from the existence of a 
pressure gradient across the AAP. Using morphological 
analysis the number of trancellular channels at any given 
time is low when compared with the number of cells with 
basal or apical openings alone.
This illustrates the temporary nature of these transcellular 
channnels. Tripathi (1971 and 1974) believes that the 
formation of a transcellular channel is a "cyclical event 
that constitutes a dynamic system of pores." The flow of AH 
through these channels is easily accounted for even if it is 
assumed that a transcellular channel exists for even l/50th 
of its total life cycle (Cole and Tripathi, 1971). 
Since at any given time only a small number of channels may 
exist this offers another explanation for the resistance to 
flow in this area of the outflow system. These channels 
often take tortuous courses through a cell and AH flows down 
a pressure gradient through these channels into the lumen of 
the AAP. There is probably no retrograde flow of AH through 
these channels since the apical openings are far smaller 
than and not directly opposite the basal openings and 
because of a possible contractile property as indicated by 
the presence of cellular cytoplasmic filaments.
Other possible drainage mechanisms include 
intercellular drainage and micropinocytosis.
Intercellular drainage
The Intercellular drainage involves the passage of AH 
across the poorly developed tight and/or gap junctions which 
exist in cellular linings of the aqueous plexus. These
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junctional complexes present a barrier to the flow of 
molecules greater than lOnm.
Although some workers believe that this is the major 
outflow route for aqueous humour (Shabo et al., 197 3) 
considering the number and size of these intercellular 
pathways this route would appear to account for only a very 
small percentage of the total drainage of aqueous humour 
(Bill, 1975).
Micropinocytosis
Micropinocytosis is an oxygen - dependent energy - 
requiring process. It involves the uptake of AH into small 
vesicles which are transported across the cells of the inner 
wall endothelium. Again, views on the importance of this 
process in AH outflow are contradictory although the 
concensus of opinion is that it does not play a major role 
in the bulk outflow of AH at normal intraocular pressures 
(Fine, 1964;Feeney and Wissag, 1976; Grierson and Lee, 1975)
Non-conventional drainage routes.
Uveoscleral pathway.
In this pathway AH flows from the chamber angle into 
the spaces between the bundles of cilary muscle, which in 
turn open into the suprachoroidal and supraciliary space. 
From here, fluid can pass across the sclera or along the 
perivascular spaces of the large blood vessels penetrating 
the sclera. This pathway appears to be independent of lOP 
changes.
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According to Bill (1966), the proportion of AH leaving 
via the uveoscleral route in rabbits is less than 2.8% 
compared with 35% in monkey. On morphological grounds this 
is expected due to the poorly developed ciliary muscle in 
the rabbit. However, Tripathi and Cole (1976), using blue 
dextran and fluorescein - dextran to trace the drainage 
routes, suggest that as much as 25% of the drainage of AH in 
the rabbit is via the uveoscleral route.
Accessory drainage routes of lesser significance 
include diffusion across iris vessels, posterior 
drainage,and trans-corneal flux (Tripathi, 1977).
Exit channels
AH is normally drained from the lumen of the AAP by the 
scleral (deep and intracleral), episcleral and sub 
conjunctival venous plexuses.
From the AAP, AH drains into several collecting 
channels which are in turn connected to the deep scleral 
venousplexus (DSVP) which drains into the anterior ciliary 
veins. The DSVP is also connected to the intrascleral venous 
plexus (IVP). The IVP drains into the episcleral and 
subconjunctival venous plexuses.
In 1942, Ascher demonstrated colourless superficial 
vessels of the globe which contained AH, which were termed 
"agueous veins".
In both rabbits and primates a variable proportion of 
aqueous passes forward to reach the episcleral and 
subconjunctival veins directly through the aqueous veins 
(Gazala e^ al_., 1965). In rabbits these aqueous veins
sometimes contain blood mixed with aqueous.
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Innervation of the tissues in the iridocorneal angle.
Many studies have been undertaken to demonstrate the 
structure and function of nerve in the angular region of 
vertebrates. Both sensory and autonomic nerve endings have 
been demonstrated with species variations. The rabbit has a 
sparse innervation of the irido-corneal angle (Ehinger
1966).
Ciliary body and ciliary processes.
In the rabbit eye, the ciliary processes have a 
delicate but rich innervation of both adrenergic and 
cholinergic fibres. The bulk of the ciliary body receives a 
sparse innervation of adrenergic fibres, although a band of 
adrenergic fibres is present above the ciliary epithelium. 
In contrast, both the ciliary stroma and ciliary muscle are 
crowded with a dense innervation of fine cholinergic fibres. 
Evidence for the presence of both adrenergic and cholinergic 
fibres in the trabecular meshwork is contradictory.
Using the histofluorometric technique of Falck (1962) 
to identify adrenergic nerve terminals, and the localization 
of acetylcholinesterase to identify cholinergic innervation, 
Laties and Jacobowitz (1964), showed that the filtration 
area in rabbits received a moderate, but definite supply of 
adrenergic and cholinergic fibres. Autoradiographic studies 
of the uptake of catecholamines have shown a predominance of 
sympathetic nerve terminals in the irido-corneal and 
scleral-trabecular areas of rabbits (Bhattacherjee, 1972).
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In rabbits, adrenergic fibres are seen scattered in the 
loose tissue of the trabecular region around the spaces of 
Fontana (Staflova, 1969).
In monkey, adrenergic and cholinergic nerve terminals 
in the trabecular meshwork are located mainly in the 
posterior part, just anterior to the insertion of the 
longitudinal ciliary muscle. About one third of these were 
adrenergic (Nomura and Smelser, 1974). Sensory nerve, 
endings as loops or free terminals have also been 
demonstrated in the trabecular meshwork.
In contrast Holland et ^ . , (1957) concluded that
many of the trabecular axons were in fact parasympathetic in 
nature and only a small number were derived from the sensory 
trigeminal and sympathetic systems. Gwin, Gelatt and Chiou 
(1979) found little evidence for cholinergic axons in the 
meshwork.
Sensory nerves, ending as loops or free terminals have 
also been demonstrated in the trabecular meshwork (Laties 
and Jacobowitz, 1964).
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Adrenergic Pharmacology Of The Eye.
In opthalmology the medical treatment of glaucoma is a 
subject of principle concern. Glaucoma is a disorder of the 
eye in which intraocular pressure (lOP) is abnormally high 
and if this increased lOP remains unchecked it leads to loss 
of visual acuity and eventual blindness. Although the 
therapeutic value of many anti-glaucomic drugs has been 
established the mechanisms whereby these drugs are effective 
in controlling lOP still remain uncertain. Adrenergic 
agonists and antagonists are effective in lowering lOP and 
are used to treat glaucoma.
Adrenaline is used widely in the treatment of glaucoma. 
The effects of adrenaline on aqueous humour dynamics and lOP 
have been studied mainly in rabbits. Although the rabbit 
differs from primates in certain aspects of the anatomy and 
morphology of the anterior chamber angle the physiological 
similarities have often been stressed. (Tripathi, 1971; 
Grierson, 1976). The current state of knowledge on the 
mechanism of adrenaline on the rabbit eye with reference 
mainly to primates will therefore be discussed.
It is now well established that the adrenergic 
responses are mediated by two major types of receptors, the 
so called alpha and beta receptors (Alqvist, 1948). The 
subdivision of the beta receptors into the beta-1 and beta-2 
subtypes was proposed by Lands lat al in 1967. The beta-1 
subtype is involved in stimulation of the heart, whereas 
vasodilation and bronchodilation are mediated by beta-2 
receptors.
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In the past decade alpha receptors have been differentiated 
into alpha-1 and alpha-2 receptors on the basis of the 
selectivity of various agonists and antagonists for these 
receptors. Alpha-1 receptors usually have a presynaptic 
location whereas alpha-2 receptors have a postsynaptic 
location (Langer, 19 74). In general, alpha receptors 
respond to catecholamines in the ascending potency order of 
phenylephrine, noradrenaline (NA) and isoprenaline, whereas 
beta receptors respond in the reverse order. NA is released 
from postganglionic sympathetic nerves whereas adrenaline is 
secreted from the adrenal medulla. Although the
iris-ciliary body and the angular aqueous plexus receive a 
sparse innervation of adrenergic fibres, studies using 
mainly radioligand binding techniques have shown that these 
structures contain adrenergic receptors. In rabbit, the 
ciliary processes contains mainly beta receptors (Neufeld 
and Page, 1977; Neuf eld et ^ .  , 1978; Page and Neufeld,
1978; Lahav et ^ .  , 1978; Dafna et ^ .  , 1979; Bromberg et 
al. , 1980; Tsukahara et ^ .  , 1980), whereas the ciliary
muscle contains mainly alpha receptors (van Alphen et , 
1965; Kern, 1970). By interacting with these receptors NA 
released from nerve terminals, circulating NA and adrenaline 
and exogenously applied NA and adrenaline have the 
opportunity to alter aqueous humour dynamics by effects on 
aqueous humour inflow and/or outflow.
The mechanisms underlying the hypotensive effects of 
adrenergic agonists and antagonists have been the interest 
of many investigators.
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Many experiments have been conducted in rabbits, some 
in monkeys, a few in cats and other species.
Changes in lOP are the final result of many tissues 
interacting in a complex manner. The diversity of the 
adrenoceptors found in ocular tissues (Holland et , 1957; 
Laties and Jacobowitz, 1964; Ehinger, 1966; Stafl^w, 1969 
and Nomura and Smelser, 1974), the lack of specificity of 
the various adrenergic agonists and antagonists which lower 
lOP (Rowland and Potter 1980) and the differences in the 
ocular structures (Tripathi, 1971, 1974) and the responses 
to these drugs in different species make it difficult to
describe precisely how adrenaline may bring about changes in 
TOP.
The Effect Of Adrenaline On lOP In The Rabbit.
Early evidence demonstrated that electrical stimulation 
of the cervical sympathetic nerves could produce ocular
hypotension (Wesley, 1908). Subsequently, it was shown that 
acute or chronic administration of adrenaline to the rabbit 
eye lowered lOP. This response to adrenaline may or may not 
be preceded by a short-lived rise in lOP. The hypertensive 
phase occurs half-an-hour to one hour after the application
of adrenaline and may last at the most for forty five
minutes. The hypotensive response is not apparent usually 
until at least two hours following adrenaline application 
and is maximal after four to five hours.
Adrenaline stimulates both alpha and beta receptors. 
In an attempt to elucidate the receptors involved in the IOP 
responses to adrenaline, many studies have examined the 
ocular responses to selective alpha and beta agonists, as 
well as the I OP responses to adrenaline in the presence of 
selective alpha and beta receptor antagonists.
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The effects of adrenaline on AH production, its 
drainage from the eye and on episcleral venous pressure have 
been the basis of experimental studies which have attempted 
to identify the cause of the pressure responses to 
adrenaline in several species. Changes in at least one of 
these parameters are likely to be responsible for the TOP 
responses to adrenaline.
The hypertensive response to adrenaline.
Depending on the dose, frequency of application, and 
the route of administration, adrenaline may produce a 
transient rise in TOP. Such a response has been reported in 
rabbit (Norton and Vierstein, 1972; Langham and 
Krieglestein, 1976; Lamble, 1977; Rowland and Potter, 1981), 
monkey (Bill, 1969) and in man (Lea, 1958; Kronfield 1971; 
Wilkie, 1974).
This rise in lOP appears to be a dose-related 
phenomenon. Low doses of adrenaline (0.5 to 2%) decrease 
I OP whereas higher doses (4 to 10%) increase and then 
decrease TOP. (Norton and Vierstein, 1979). In contrast, 
concentrations as small as 0.1 to 1% can cause a minor 
transient rise in lOP (Innemee and van Zwieten,1982).
The hypertensive phase can be observed with initial 
application (acute) (Lamble, 1977; Rowland and Potter, 1981; 
Potter et ^ .  , 1982, 83) or it can be manifested only on
repeated exposure on consecutive days (chronic) (Unger, 
1979; Langham and Krieglestein, 1981).
Norton and Vierstein (19 79) reported that this 
hypertensive phase was a function of the administration
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site. After two hours, topically applied adrenaline 
produced a transient elevation of lOP in 75% of the rabbits 
treated. No such rise was found in animals treated with 
adrenaline via the intravitreal or retrobulbar route.
Both alpha and beta receptors appear to be involved in 
the hypertensive réponse to adrenaline. When applied 
topically to the rabbit eye, chronic administration of low 
doses of adrenaline produced a hypertensive response which 
was partially blocked by the beta antagonists propranolol 
and timolol (Langham and Krieglestein, 1976) and the alpha 
antagonist phenoxybenzamine (Langham and Krieglestein,
1976). The hypertensive response to single doses of high 
concentrations of adrenaline (4,8, and 10% solutions) were 
similarly blocked by propranolol (Norton, 19 72; Lamble, 
1974). However, Langham and Krieglestein, (1976) have shown 
that intravenous or topical application of propranolol did 
not alter the hypertensive response to chronic adrenaline 
treatment. Concurrent topical administration of the alpha 
antagonists phenoxybenzamine and thymoxamine with adrenaline 
on the third day of treatment abolished the hypertensive 
response but not the hypotensive response. Pupil diameter 
responses remained unaltered. The effect of intravenous 
phenoxybenzamine on the hypertensive response to adrenaline 
was difficult to interpret since phenoxybenzamine lowered 
I OP on its own. Rowland and Potter, (19 78) demonstrated a 
positive association between alpha receptor stimulation and 
the manifestation of a transient rise in I OP following 
single dose applications of adrenergic drugs.
Selective alpha and beta receptor agonists also produce 
an initial rise in lOP. Phenylephrine and St. 587 (a
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selective alpha agonist), when topically administered to the 
rabbit eye, caused an increase in lOP with a maximal effect 
within one hour (Inneme et a^., 1982). In contrast BHT 920, 
a selective alpha - 2 agonist, produced an immediate fall in 
lOP. These results indicate that the alpha - 1 subtype is 
involved in ocular hypertension.
Chronic treatment with reproterol, a relatively 
selective beta - 2 agonist, increased lOP, an effect
antagonised by timolol pretreatment (Potter et , 1982,
1983).
There is a temporal difference in the hypertensive
response to acute as compared to chronic administration of 
adrenergic agonists. The ocular hypertensive response to a 
single dose of alpha adrenergic stimulants, for example,
dopamine, NA, adrenaline or phenylephrine, peaked more
rapidly (within half-an-hour after administration) and was 
short-lived. In contrast, the response to repeated
consecutive doses of beta adrenergic agonists, for example 
1-adrenaline, isoprenaline and reproterol, tended to peak 
more slowly (one to two hours after administration), were 
longer lasting and were usually much greater in the 
magnitude of the change. In functional terms the early 
ocular hypertensive phase caused by adrenaline may be 
attributed to:
1) an increase in intra-and episcleral venous pressure,
2) an increase in aqueous humour production,
3) enhancement of extraocular muscle tone,
4) the generation of prostaglandins.
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The effect of adrenaline on episcleral venous pressure.
AH leaves the anterior chamber mainly by bulk flow 
through the trabecular meshwork and eventually flows via the 
intrascleral plexus into the episceral veins. The
intrascleral plexus has vessels containing blood and/or 
aqueous humour. Convergence of these vessels at the 
episcleral veins, therefore, provides several loci where 
vasomotor responses could conceivably facilitate or restrain 
flow. Langham and Krieglstein (19 76) have suggested that 
interaction with alpha receptors on these veins could result 
in vasoconstriction, which would increase the resistance to 
flow and therefore increase lOP. Although in rabbits there 
is no reported evidence of a rise in episcleral venous 
pressure soon after the application of adrenaline, the 
application of alpha agonists induces intense blanching of 
both the conjuntival and episcleral vessels. Under these 
conditions the rate of blood flow is seen to decrease 
(Langham and Krieglstein, 1976). In the rabbit eye, a small 
hypertensive response to repeated daily application of NA 
was associated with an increase in outflow resistance 
(Langham and Palewicz, 1977). In man, episcleral venous 
pressure has been measured following adrenaline treatment 
(Wilke, 1974). Such measurements were made on recipient 
veins i.e. an episcleral vein which had just received a 
large aqueous vein. In these experiments topical
application of a 1% solution of adrenaline produced a 
transient rise in I OP which was maximal within 15 minutes. 
Adrenaline produced an obvious vasoconstriction of 
conjuntival blood vessels and a rise in episcleral venous
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pressure almost immediately after its administration. These 
workers therefore suggested that the rise in I OP may have 
been secondary to a rise in episcleral venous pressure.
Similarly in the monkey adrenaline and isoprenaline 
tended to increase recipient venous pressure, although there 
was also a rise in total facility of outflow (Bill, 1970). 
Other investigations in the human eye found no changes in 
episceral venous pressure following the topical application 
of adrenaline or isoprenaline (Kupfer et ^ .  , 1971;
Gaasterland et , 1973).
The effect of adrenaline on AH production.
Since beta-2 receptors are present in the ciliary 
processes and are proposed to be involved in AH formation 
(Nathanson, 1980) it is possible that adrenaline may well 
increase AH production by stimulation of these receptors 
(Potter et ^ .  , 1981). Several workers have reported
decreases in AH formation following adrenaline treatment 
(Masuda, 1971; Green and Padget, 1979; Miichi and Nagataki,
1982). Although this adrenaline-induced decrease in AH 
inflow would tend to decrease lOP, these measurements were 
taken several hours after adrenaline treatment which 
coincides with the hypo- and not the hypertensive response 
to adrenaline. Therefore, to determine the role of AH 
production in the hypertensive response to adrenaline, AH 
formation should be measured soon after adrenaline 
administration. Lamble (1977) has investigated the acute 
effects of adrenaline on AH formation. Using tritiated 
water as a model of a rapidly diffusing molecular species.
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the effects of adrenaline on its transfer from the blood to 
the aqueous was investigated. Following intravenous
injection of triated water, topically applied adrenaline 
caused a concentration-related decrease in tritium 
penetration into the anterior chamber at thirty and sixty 
minutes after its administration. No effect was seen two to 
three hours later. The clearance of radiolabelled inulin
which had been injected into the anterior chamber was also 
investigated. One hour after adrenaline treatment there was 
a significantly higher level of radioactivity in the AH, 
indicating decreased clearance. Again these results suggest 
that adrenaline decreases AH formation. It therefore seems 
that adrenaline's hypertensive response is not a result of 
increased AH production. However, it is interesting to note 
that approximately one hour following adrenaline treatment, 
Lamble (1977) reported a rise in facility of outflow but no 
fall in lOP and suggested that this was a result of an
adrenaline-induced rise in inflow. In support of this 
theory Cole and Nagasubramanian (19 73) have shown, in vitro, 
that NA and isoprenaline increased the ciliary
transepithelial short circuit current.
The effect of adrenaline on extraocular muscles.
In 1976, Allen and Langham found an initial rise and 
then fall in IOP after the local administration of clonidine 
(an alpha agonist). Subsequently it was found that this 
rise could be blocked by phenoxybenzamine or muscle
relaxants. Innemee and van Zwieten (1978), therefore 
proposed that this rise in IOP involved alpha receptors and 
was a result of the contraction of extraocular muscles.
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Earlier experiments showed that systemic adrenaline 
increased the tension in extraocular muscles in the cat eye 
(Eakins and Katz, 1968). In an attempt to determine whether 
or not the hypertensive phase to adrenaline involved 
extraocular muscles, Rowland and Potter (1980) surgically 
transected the three major extraocular muscles in the rabbit 
eye. In control animals a single dose of 2% adrenaline 
applied topically evoked a biphasic response which was 
significantly hypertensive after half to one hour. In 
contrast, the hypertensive responses to chronically 
administered reproterol and adrenaline were not abolished in 
rabbits with transected extraocular muscles (Potter, 
Nicholson and Rowland 1982, 1983). However, in conjunction 
with these experiments a separate series of control 
experiments was carried out in which adrenaline failed to 
raise lOP. This suggests that the hypertensive response to 
acute adrenaline may be inconsistent as was implied by the 
observation by Boas et ^ .  , (19 81) that only 10 to 15% of
rabbits tested elicited an initial hypertensive response to 
2% adrenaline.
The involvement of prostaglandins in the hypertensive 
response to adrenaline.
Destruction, either surgically or chemically of the 
cervical sympathetic nerves in rabbits was found to enhance 
the ocular hypertensive response to topically applied NA or 
phenylephrine (Unger, 1979; Waitzman et al., 1979).
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This enhanced response was blocked by indomethacin or 
phentolamine pretreatment. These results suggest that 
prostaglandins released under such circumstances are closely 
linked to alpha receptor stimulation. However, the ocular 
hypertensive response to chronic administration of NA, 
phenylephrine and isoprenaline remained unaltered following 
pretreatment with inhibitors of prostaglandin biosynthesis. 
(Unger, 1979; Potter et ^ . , 1982, 1983) suggesting that the 
generation of prostaglandins was probably not involved in 
raising lOP.
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The Hypotensive Response To Adrenaline
In the rabbit eye, adrenaline lowers lOP in a 
dose-dependent fashion (Norton and Vierstein, 1972). This 
hypotensive response is independent of the administration 
site since topical application, intravitreal, retrobulbar or 
intravenous injection of adrenaline lowers lOP (Norton and 
Vierstein 1972; Langham et a]^ . , 1973). Either acute or
chronic administration of adrenaline lowers lOP (Langham and 
Krieglstein, 1976), although there is conflicting evidence 
that this response may gradually decline during continuous 
use (Langham and Diggs, 1972; Bhattacherjee and Hammond,
1977) .
Following the topical application of low doses of 
adrenaline (0.1 to 1%), the change in IOP follows a 
characteristic timecourse. In the absence of a hypertensive 
response there is no significant alteration for at least one 
hour, then lOP begins to fall and reaches a maximal response 
four to six hours after the administration of adrenaline 
(Lamble, 1974; Langham and Krieglestein, 1976; Lamble, 1977; 
Inneme and van Zwieten, 1982). This slow process is in 
marked contrast to the characteristic rapid fall in lOP 
produced by beta agonists. Selective beta agonists, for 
example, salbutamol, metaproterenol, BHT-920 and 
terbutaline, produced a significant pressure decrease within 
one hour with a maximal response attained within two to 
three hours (Langham and Diggs, 1974; Innemee et ^ . , 1982).
Several experiments have suggested that the delay in 
the onset of the hypotensive response to adrenaline is due 
to the hypertensive response which temporarily negates the
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hypotensive response (Lamble, 1977; Rowland and Potter,
1978). However, although the hypertensive response to 
adrenaline is blocked by propranolol, propranolol did not 
alter the time of onset of the hypotensive response (Lamble, 
1974). Thymoxamine, an alpha antagonist, reduced the
delay of the onset of this response, which suggests a role 
of alpha receptors in mediating this delay (Lamble, 1977). 
The ocular responses to adrenaline applied topically to 
primate and human eyes are qualitatively very similar to 
those in rabbits (Kitazawa and Langham, 1978; Langham et 
al.,1971).
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Adrenoceptors Involved In The Hypotensive Response To 
Adrenaline.
Adrenaline stimulates both alpha and beta adrenoceptors.
To date the majority of evidence suggests that the 
hypotensive response to adrenaline in the rabbit eye 
involves mainly beta adrenoceptors although an alpha 
adrenoceptor-mediated effect on inflow may also be involved.
However, the relative importance of each of these 
subclasses remains uncertain. The availability of highly 
selective beta-1 and beta-2 receptor antagonists and 
relatively selective alpha receptor antagonists may allow a 
more profound analysis of this ocular hypotensive response.
The effects of selective and non- selective beta 
antagonists on the ocular responses to dipivalyladrenaline 
(DPA), a prodrug for adrenaline, were investigated by 
Innemee and van Zwieten (1982). The selective beta-1
antagonists, atenolol and metoprolol did not lower lOP and
had no effect on the hypotensive response to DPA.
Although low concentrations of the non-selective beta 
antagonists (timolol) and selective beta-2 antagonists (IPS 
339,ICI 118-551 and 32-468 hmo) lowered lOP they also 
antagonised the hypotensive response to DPA.
Although intravenous injection of propranolol (5mg
kg  ^) did not alter lOP, it did reduce the hypotensive 
response to 0.5% adrenaline (Langham et ^ . , 1973).
Similarly, in the rabbit and monkey eye, pretreatment with 
propranolol antagonised the rapid fall in lOP induced by 
topically applied isoprenaline and salbutamol (Langham and 
Diggs, 1974). However, topical pretreatment with timolol
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had no effect on the hypotensive response to adrenaline 
(Boas et aj.. y 1982). In these experiments 2% adrenaline 
produced a fall in I OP as late as six hours following its 
administration with a maximal response between eight and 
twelve hours.
In 1968, Potter and Rowland concluded that relatively 
selective alpha receptor agonists, for example phenylephrine 
and NA were minimally effective in lowering I OP whereas 
drugs with more beta adrenoceptor stimulating activity, for 
example, adrenaline and isoprenaline were very active in 
lowering lOP. Ihese authors, therefore, suggested that 
selective beta adrenoceptor stimulation is an effective 
mechanism for lowering lOP.
In earlier papers, Langham et ^ .  , (1972, 1973, 1976,
19 77) concluded that alpha receptors were primarily involved 
in the ocular hypotensive response to adrenaline.
However, examination of these papers shows that such a 
conclusion cannot be drawn from the results presented. 
Topical, IV, or intravitreal administration of 
phenoxybenzamine, propranolol and thymoxamine lowered I OP 
and, therefore, the ability of these drugs to antagonise the 
acute hypotensive response to adrenaline could not be 
properly investigated. Similarly, intravenous injection of 
phenoxybenzamine failed to block the hypotensive response to 
NA (Langham and Paliewicz, 1977). In contrast, IV 
pretreatment with phenoxybenzamine one day prior to 
adrenaline treatment blocked the outflow response to 
intracamerally injected NA (Sears and Sherk, 1974).
Despite some conflict in the literature most 
observations are compatible with the theory that adrenaline 
lowers lOP by stimulating beta adrenoceptors.
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The Mechanism of Action of Adrenaline in Lowering lOP 
The effect of adrenaline on AH formation.
It has been suggested that adrenaline lowers lOP at 
least in part by decreasing AH formation. A fall in AH 
production which precedes the adrenaline-induced fall in lOP 
has been reported (Lamble, 1977). Adrenaline may decrease 
inflow by acting on blood vessels supplying the ciliary 
processes.
Although there are no nerves within the ciliary 
epithelial layers, alpha receptors are probably present in 
the blood vessels supplying the stroma. Vasoconstriction of 
these vessels would decrease blood flow thereby limiting the 
plasma filtrate entering the stroma and AH production may 
therefore be decreased.
Sympathetic cervical stimulation causes intense uveal 
vasoconstriction, an increase in vascular resistance and a 
fall in uveal blood flow. These vessels also respond £o 
injected NA but not to isoprenaline suggesting the presence 
of alpha but a lack of beta receptors. (See review by Sears,
1967).
In rabbit and monkey, stimulation of the sympathetic 
cervical chain, which releases NA from nerve terminals, 
produces a decrease in AH formation and a fall in lOP 
(Langham and Rosenthal, 1966; Bill, 1970).
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The rate of AH formation can be determined
experimentally using a variety of tracer dilution 
techniques. By perfusing the anterior chamber of the rabbit 
eye with fluorescein-dextran, and measuring its 
concentration in samples of AH taken from the anterior 
chamber, Miichi and Nagataki (1982) investigated the effects 
of several adrenergic agonists and antagonists on AH 
formation in the rabbit eye. Two hours after the topical 
application of adrenaline and NA into a conjunctival
reservoir both AH formation and lOP were lowered. Topical 
adrenaline and NA also reduced AH formation as determined by 
volumetry after cannulation of the anterior chamber (Masuda, 
1971). Green and Padgett (1979) determined the rate of AH 
formation by means of radioactive inulin dilution and 
similarly showed that two hours after the topical 
application of adrenaline and NA, AH formation was decreased 
although pseudofacility was increased. It should be noted 
that in all of these procedures experimental manipulation
may well result in trauma of the eye which could ultimately 
alter the parameters measured. In 1977, Lamble also 
reported that adrenaline decreased inflow in the rabbit eye.
However, by the time the hypotensive response to adrenaline 
was apparent, the observed decrease in inflow was already 
waning.
In the rabbit eye, neither salbutamol, a selective
beta-2 agonist, nor timolol, a non-selective beta antagonist 
altered AH formation (Miichi and Nagataki, 1982).
The effects of relatively selective alpha and beta 
agonists on AH production have been investigated in the 
primate eye.
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In the monkey eye, adrenaline had no effect on the rate 
of AH formation (Bill, 1969). This may be due to the 
antagonistic effects of adrenaline on AH formation, i.e., a 
direct stimulatory effect on the secretory mechanism could 
be masked by a reduction in AH formation resulting from a 
vasoconstriction of blood vessels supplying the stroma.
Bill (1970) determined the rate of AH formation in the 
vervet monkey and found that intracamerally perfused 
isoprenaline (1 g.ml ^ ) increased the rate of AH formation. 
This response was antagonised by propranolol pretreatment. 
In these experiments NA had only a slight effect on inflow.
Miichi and Nagataki (1983) studied the effects of 
salbutamol and timolol on the rate of AH formation in the 
cynomolgus monkey. Although these drugs were applied into a 
conjunctival reservoir, anterior chamber concentrations were 
comparable to the concentrations infused by Bill (1970) into 
the vervet monkey eye. Salbutamol increased, whereas 
timolol decreased the inflow rate. Thus both these studies 
agree that beta adrenergic agonists tend to increase and 
beta adrenergic antagonists tend to decrease the rate of AH 
formation in the monkey eye.
In man, AH formation is usually determined by a 
fluorophotometric technique. Development of this technique 
has allowed a more direct measurement of AH inflow which had 
previously been calculated from manometrically determined 
facility of outflow values. Nevertheless, results from 
studies using this technique have been in disagreement. 
Adrenaline was reported to decrease AH inflow, one, ten and 
twenty four hours following its instillation (Weekers, 1954; 
Gaasterland et 1973; Nagataki, 1977). In contrast.
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Townsend and Brubaker (1980) observed that a single dose of 
adrenaline increased AH production two to three hours 
following its administration. Similarly, Schenker et al., 
1981) showed that adrenaline, when given for a week, 
produced an increase in AH production two to five hours 
after the last dose.
Following a detailed analysis of the reponses of ocular 
hypertensive patients to adrenaline, Kronfeld (1971) 
concluded that adrenaline failed to show consistent effects 
on AH inflow, either initially or during chronic treatment.
In the human eye, NA increases inflow and decreases 
lOP, whereas phenylephrine has no effect on either inflow or 
I OP (Gaasterland et ^ . , 1973; Lee and Brubaker, 1982,
1983). The concensus of opinion suggests that alpha 
agonists have no appreciable effects on inflow. 
Isoprenaline, a non-selective beta agonist, and timolol, a 
non-selective beta antagonist decrease both inflow and lOP 
in man (Gaasterland et ^ . ,  1973; Zimmerman, 1977; Sontag et 
al., 1978; Boger, 1978; Coakes, 1978; Yablonski et al.,
1978; Higgins et ^ .  , 1980; Thomas ^  ^ . , 1981).
The effect of adrenaline on the facility of outflow of AH.
Adrenergic agents have pronounced effects on the 
facility of outflow of AH. Topical or intracameral 
injection of adrenaline increases the facility of outflow of 
AH from the rabbit eye (Eakins, 1963; Bill, 1969; Lamble, 
1974; Lamble, 1977). Using pressure decay curves to
calculate the facility of outflow, Eakins (1963) showed that
in the rabbit eye intravitreal injections of adrenaline, NA,
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but not isoprenaline increased the facility of outflow after 
their administration.
Lamble (1974) measured facility of outflow using a 
constant pressure perfusion technique. This measures total 
facility of outflow which is a combination of both true and 
pseudofacility. In these experiments, topically applied 
adrenaline increased the facility of outflow of AH one to 
six hours following its administration. A conspicuous 
feature of this study was the lack of a relationship between 
adrenaline's effects on facility and on lOP. Large facility 
effects were not accompanied by significant differences in 
tension. However, in these and subsequent experiments 
(Lamble, 1977) the effect of adrenaline on ocular tension 
was apparently reduced or reversed by the procedures of 
anaesthesia and cannulation performed to allow facility 
determination and may, therefore, explain this apparent 
disparity. Ihus it was reasonable to conclude that the fall 
in lOP caused by adrenaline was related to the facility 
effect.
The resistance to the outflow of AH associated with the 
hypotensive response to NA has been analysed manometrically 
by a two-level constant pressure perfusion technique in the 
anaesthetised rabbit (Langham and Palewicz, 1977). Five 
hours following a single dose of NA, a significant decrease 
in lOP and outflow resistance was observed. In a separate 
series of experiments, facility was determined by measuring 
the steady-state increase in lOP caused by infusion of 
saline (Sears, 1960; Sears and Scherk,1964). Although NA
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increased facility of outflow in both the innervated and 
denervated eye, the response was larger following unilateral 
superior cervical ganglionectomy. In these experiments, NA 
injected intracamerally was more effective in raising 
facility than NA injected subconjunctivally.
Using a manometric technique to measure facility of 
outflow in the monkey eye, topically applied adrenaline 
increased the gross facility of outflow one hour after its 
application (Bill, 1969). Since pseudofacility was
unaffected by adrenaline, this rise in gross facility of 
outflow was attributed to the observed rise in 
pressure-dependent and independent outflow, that is through 
the canal of Schlemm and uveoscleral routes respectively. 
The lack of an effect on pseudofacility was probably due to 
the high arterial blood pressure found in these experiments.
Topical or intracameral injection of adrenaline 
produced a rise in true facility of outflow thirty to sixty 
minutes after its administration (Barany, 1968; Kaufman and 
Barany, 1981). Associated with this early rise in facility 
was an increase in pseudofacility (Barany, 1968).
Adrenergic agents which have a greater selectivity for 
either alpha or beta receptors can also alter facility of 
outflow.
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Bill (1970) examined the effects of intracamerally 
injected isoprenaline and adrenaline on AH dynamics. 
Isoprenaline increased the gross facility of outflow, 
enhanced uveoscleral flow and increased AH inflow. These 
effects were blocked by pretreatment with propranolol. 
Although isoprenaline increased recipient venous pressure 
and therefore tended to increase lOP, these changes were 
small and statistically insignificant.
Stimulation of the cervical sympathetic nerves in 
monkey, which releases NA into the uvea, increased AH 
formation and decreased lOP but had no effect on the 
facility of outflow (Bill, 1970). However, exogenous NA had 
no effect on any of the afore-mentioned parameters. In 
contrast, Kaufman and Barany (1981) reported that NA 
injected into the anterior chamber of the monkey eye 
increased the gross facility of outflow.
In man the facility of outflow of AH is measured 
indirectly using tonography. Unlike constant pressure 
perfusion, tonography measures only pressure-dependent 
outflow while pressure-independent outflow through the 
uveoscleral route has to be calculated.
In humans. Sears (1966) proposed that topical 
adrenaline lowered lOP in three ways: (1) an early decrease
in lOP related to a decrease in AH inflow, (2) an early rise 
in facility of outflow overlapping with the fall in inflow 
and (3) a progressive increase in outflow facility with 
chronic medication.
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In 1971, Kronfeld further investigated the early 
effects of single and repeated doses of adrenaline in 
patients with ocular hypertension and primary open angle 
glaucoma. In these patients single doses of adrenaline did 
indeed produce a fall in lOP, approximately one hour after 
its administration, which was associated with a rise in 
facility of outflow. However, no consistent effect on 
outflow could be observed. These effects were most 
pronounced on the day of treatment, were still present on 
the post-treatment day and were returning to control values 
on the second post-treatment day. Chronic administration of 
adrenaline appeared to produce a steady state, where the 
responses were on the whole somewhat greater than those to 
single doses although no significant upward or downward 
trend was apparent.
Although in normal or hypertensive human eyes, acute or 
chronic administration of adrenaline increases tonographic 
facility of outflow this rise alone cannot explain the fall 
in lOP. In addition to this rise, adrenaline has been
reported to increase uveoscleral outflow, and together these 
increases can account for the fall in I OP (Townsend and
Brubaker, 1980; Schenker et ^ . , 1981).
Salbutamol also increases both tonographic facility of 
outflow and uveoscleral flow in the normal human eye,
although pressure-dependent flow was reduced (Coakes and 
Siah, 1984). Contrasting results from Gaasterland et al. , 
(1973) demonstrated an adrenaline-induced fall in facility 
although this could be attributed to a reduction in
pseudofaclity.
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Structures Involved In the Adrenaline-Induced Rise In 
Facility Of Outflow.
The primary target structures responsible for the 
adrenaline-induced rise in facility are unknown. Candidates 
proposed include:
1) the anterior portion of the ciliary muscle
2) the iris
3) the trabecular meshwork (and/or the canal of Schlemm in 
primates)
Iris and ciliary muscle involvement
In primates the ciliary muscle inserts at the scleral 
spur and trabecular meshwork, so that ciliary muscle tone 
may markedly influence outflow facility. Adrenergic
terminals found in primates, are for the most part, located 
just anterior to the insertion of the ciliary muscle. the 
adrenoceptors of the ciliary muscle of several monkey 
species are purely beta (Van Alphen et , 1965) .
Activation of these receptors tends to relax the ciliary 
muscle and to decrease outflow facility.
In rabbits, the possible involvement of ciliary muscle 
tone in modulating AH outflow is more tentative. In the 
rabbit the ciliary muscle is poorly developed and due to the 
absence of the scleral spur and Schlemm's canal, its 
insertion at the anterior chamber angle differs from that in 
monkeys. Nonetheless there is a forward prolongation of
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ciliary muscle cells into the filtration angle (Sakimoto, 
1979). Adrenergic innervation of this muscle is very 
difficult to find, although Staflova (1969) and 
Bhattacherjee (19 72) have reported the presence of 
adrenergic fibres in the loose tissue of the trabecular 
region and the spaces of Fontana. Rabbit ciliary muscle 
contains mainly alpha receptors (Van Alphen et , 1965). 
Contraction of the ciliary muscle, as a result of 
interaction with these receptors would tend to increase 
outflow faclity.
In rabbit, stimulation of the cervical sympathetic 
nerves contracts the ciliary muscle (Van Alphen et al. , 
1965) but does not alter outflow facility (Langham and 
Rosenthal, 1966; Paterson, 1966) . The lack of any rise in 
facility may be a result of the sparsity of the ciliary 
muscle. Eakins and Eakins (1964) found that in rabbits 
pretreated with cocaine, stimulation of the sympathetic 
nerves raises the concentration of NA in the AH, but without 
cocaine no rise was observed. Paterson (1966) found that in 
cocaine-pretreated rabbits there is a marked rise in outflow 
facility during sympathetic stimulation.
Stimulation of the cervical sympathetic nerves in the 
monkey relaxes the ciliary muscle (Tornqvist, 1966) which, 
as expected decreases outflow facility (Casey, 1966). 
However, both adrenaline and NA increase facility of outflow 
(Barany, 1968; Bill, 1969; Bill, 1970). This can be 
explained by an adrenaline-induced rise in pseudofacility 
(Barany, 1968) although this is not enough to account 
totally for the rise in outflow facility. Alternatively, a 
rise in uveoscleral flow could be responsible.
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In the monkey, uveoscleral flow accounts for at least 
30% of the total aqueous flow (Bill, 1971). The 
uveoscleral flow increases after topical adrenaline and also 
anterior chamber perfusion with isoprenaline. This is 
accounted for by ciliary muscle relaxation which widens the 
spaces in the intermuscular connective tissue. (Bill, 1969; 
Bill, 1970).
The influence of ciliary muscle tone on outflow 
facility can be eliminated by disinserting and 
retrodisplacing the muscle from the spur. Kaufman and 
Barany (19 81) demonstrated that the percentage facility 
increases caused by adrenaline and NA were similar in 
disinserted and nondisinserted eyes. Drug-induced
alterations in ciliary muscle tone, therefore, could not 
have been responsible for the adrenaline-induced rise in 
facility of outflow.
The idea has been advanced that dilation of the pupil 
by adrenaline might transmit mechanical pull on the 
trabeculae and therefore increase outflow facility. This 
idea is not favoured for several reasons. Kaufman and 
Barany (1981) have shown that iridectomy has no effect on 
the outflow responses to adrenaline or NA. The increase in 
outflow produced by cAMP, the second messenger supposedly 
responsible for adrenaline's activity at beta adrenergic 
receptors, occurs without mydriasis (Neufeld et al., 1975). 
Beta receptor agonists, which have no effect on pupil 
diameter, lower lOP. (Langham and Diggs, 1974; Innemee, 
1982).
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Trabecular meshwork/canal of Schlemm
In the monkey eye adrenaline and NA increase facility 
of outflow before and after ciliary muscle disinsertion and 
iridectomy. Kaufman and Barany (19 81) therefore concluded 
that adrenaline increased outflow facility by acting 
directly on the trabecular meshwork and/or the endothelial 
lining of Schlemm's canal. However, the precise mechanism 
of action of adrenaline at these sites remains obscure. It 
has been considered most likely that adrenaline activates 
beta adrenoceptors on the endothelial cells lining the 
outflow pathway.
In rabbit and monkey there is an increase in the level 
of cAMP in the AH in response to adrenergic agonists. In an 
attempt to identify the tissue origin of this cAMP Neufeld 
and Sears (1974) investigated the ability of ocular tissues 
from rabbit, monkey and man, to generate cAMP following the 
administration of adrenergic agonists. Because of the lack 
of cAMP in the posterior chamber, it appeared that the cAMP 
in the AH must originate from some tissue lining the 
anterior chamber. Although adrenaline, NA and isoprenaline 
raised the levels of cAMP in a vitro preparation of the 
iris-ciliary body and the cornea, of particular importance 
was the rise and subsequent release of cAMP from rabbit 
scleral trabecular rings. This increase in cAMP content of 
the scleral trabecular ring tissue, which contains the site 
of decreased outflow resistance, may represent the initial 
biochemical response of the trabecular meshwork and/or 
endothelial cells to adrenergic agonists.
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similarly adrenaline increased the cAMP content of both 
human trabecular explants and cultured trabecular 
endothelial cells 15 minutes following its administration 
(Tripathi and Tripathi, 1984).
Although in most species the endothelial cells of the 
meshwork and of the canal of Schlemm are only occasionally 
innervated, nevertheless the cells lining the canal have 
mitochondria, indented nuclei and cytoplasmic rod-like 
structures, all characteristic of cells with contractile 
properties. Muscle activity of these cells triggered by 
cAMP, would by analogy with smooth muscle elsewhere, most 
likely consist of relaxation. Relaxation of cells within 
the meshwork would increase facility of outflow, if, when 
contracted they tended to draw together the trabecular bars. 
Recent studies by Tripathi and Tripathi (1984), using 
continuous phase-contrast, time-lapse micrography, have 
revealed striking changes in the dynamic cellular movement 
of human cultured trabecular endothelial cells following 
adrenaline treatment. Cell contraction was noted within 
fifteen minutes of exposure of the cells to adrenaline. 
Although cell contraction resulting from the interaction 
with a beta receptor is unusual,it would still be compatible 
with increased facility of outflow if contraction pulled the 
meshwork open in the same way as the ciliary muscle does in 
primates. An alternative hypothesis is that cAMP may well 
act as an intercellular as opposed to an intracellular 
messenger; cAMP, released from cells lining the anterior 
chamber, may act directly on "receptors" within the 
trabecular meshwork or the canal of Schlemm.
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It is known that the meshwork is coated with a mucinous 
material. In rabbit, it is coated with the hyaluronidase - 
sensitive hyaluronic acid. Such a coating provides 
resistance to outflow and may be influenced directly by 
adrenergic agents, or indirectly through cAMP. Experiments 
done in the aorta of rabbit indicate that adrenaline may 
decrease the production of mucoid substances (Sears, 1975). 
Similar effects in the trabecular meshwork, eliminating 
resistance produced by a mucoid coat, could in time decrease 
the resistance to outflow of AH.
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The Biochemical Mechanism of Action of Adrenaline In 
Lowering IOP.
A majority of results from studies which have 
investigated the effects of selective adrenergic agonists 
and antagonists on AH dynamics suggests that adrenaline 
increases outflow facility and consequently lowers lOP via a 
beta receptor. Similarly, biochemical evidence suggesting a 
beta adrenergic mechanism has also been compiled.
In many tissues adrenergic agents activate adenylate 
cyclase to produce adenosine-3',5'-cyclic monophosphate 
(cAMP) and it is this second messenger which appears to 
mediate many of the physiological events that the 
catecholamines initiate. The action of cAMP is clear, for 
example, in the effects of adrenaline on glycogenolysis in 
the liver (Exton, Robison et a]^ . , 1971) and skeletal muscle 
(Walsh et al., 1970) and on lipolysis in fat cells, (Butcher 
et al. , 1968). cAMP may also play a role in ion and fluid 
transport (Orloff and Handler, 1977).
Evidence from several sources suggests that cAMP may 
play a central role in mediating several ocular responses to 
catecholamines.
In the rabbit eye, topically applied adrenaline, NA and 
isoprenaline increased cAMP levels in the AH (Neufeld, 
Jampol and Sears, 1972) with a concomitant rise in outflow 
facility and fall in lOP. This rise in cAMP was directly 
related to the adrenaline concentration (Neufeld et ,
1973). The CAMP in the AH increased rapidly (within half an 
hour), preceded the fall in lOP by about thirty minutes and 
peaked about the same time as the minimum lOP was reached.
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This increased level of cAMP was sustained for several 
hours.
To test the relevance of this rise in cAMP to the 
ocular effects of catecholamines, the effects of exogenous 
cAMP on various ocular parameters were investigated in the 
rabbit (Neufeld, Jampol and Sears, 1972; Neufeld et al., 
1975). Intracameral injections of cAMP increased outflow 
facility and decreased lOP. Pupil diameter was unaltered. 
These responses followed a time-course similar to that of 
adrenaline. Although in the monkey eye cAMP failed, 
8-methylthio-cAMP, a potent analogue of cAMP, increased 
outflow facility. (Neufeld and Sears, 1975).
Factors which are known to influence the lOP responses 
to adrenaline also alter the levels of cAMP in the AH
(Neufeld, Chavis and Sears, 1973). Repeated daily topical 
treatment with adrenaline leads to a progressive decrease in 
the magnitude of the lOP response to the drug, while cAMP 
levels in the AH showed less increase than in acutely
treated controls. Superior cervical ganglionectomy produces 
an increased sensitivity of I OP to adrenaline and was
accompanied by enhanced rises in AH cAMP concentrations.
There are, however, findings which discount a causal 
relationship between elevated cAMP levels and a fall in lOP 
following the activation of a beta receptor. The relative 
potency of catecholamines in increasing aqueous cAMP was
reported to be in the order adrenaline, NA and isoprenaline 
(Neufeld, Jampol and Sears, 1972). This may not represent 
the order of potency, since the actual drug concentration in 
the biophase of the target tissue is unknown.
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Roland and Potter (19 79) found that the potencies of 
various catecholamines to produce a hypotensive response and 
to increase cAMP concentrations in the AH were not 
necessarily in direct relation. Systemic propranolol failed 
to block the pressure decrease and the elevation of cAMP in 
responses to NA or adrenaline treatment, whereas 
phenoxybenzamine partially inhibited them both (Neufeld, 
Jampol and Sears, 1972). Topical timolol effectively
blocked the rise in cAMP production following treatment with 
isoprenaline in the rabbit eye, but it did not alter the lOP 
responses to isoprenaline (Bartels et 1980) .
Similarly, topical pretreatment with timolol blocked the
rise in cAMP but not the fall in I OP following adrenaline 
treatment (Boas et ^ .  , 1981). In these experiments cAMP 
levels peaked as expected between sixty and ninety minutes 
followed by a second peak at 240 minutes, and had returned 
to control values by 360 minutes. However, there was no 
change in lOP until six hours after adrenaline treatment, an 
unusually long delay.
The binding of beta adrenergic agonists and antagonists 
with the receptor shows stereospecificity; the L-isomer 
shows approximately 100 times greater affinity for the 
receptor than the D-isomer. In accordance with this,
topical D-isoprenaline did not increase the cAMP
concentration in the AH but it induced a hypotensive 
response (Kass et ^ .  , 1976; Seidehamel, 1975) which was
dose-dependent and was suppressed by the beta receptor 
antagonist sotalol. (Seidehamel et al., 1975).
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Timolol and Aqueous Humour Formation.
Timolol is a non-selective beta-adreneceptor antagonist 
which is relatively devoid of sympathomimetic and local 
anaesthetic properties. Timolol has been shown to lower IOP 
in rabbit, monkey and man.
In rabbits the ocular hypotensive response to timolol 
is controversial. Topical application of a 1% solution of 
timolol failed to lower lOP in both normo- and hypertensive 
rabbit eyes. (Boas et ^  1981, Palkama, 1985). Similarly, 
Vareilles et ^ .  , (1977) reported that timolol produced only 
a slight but inconsistent lowering of lOP in the 
normotensive rabbit eye. In contrast, both timolol, and the 
highly selective beta-2 antagonist, IPS 339, lowered lOP in 
the normotensive rabbit (Nathanson et ^ .  , 1981). Timolol 
also reduced lOP which had been raised by alpha chymotrypsin 
and water loading (Vareilles et ^ .  , 1977).
In man, timolol produces a dose-dependent lowering of 
lOP in the normotensive eye (Katz et ^ .  , 1978) and is
particularly effective in the hypertensive eye. (Boger ejb 
al. , 1978; Ritch et a_l. , 1978; Williams et ^ .  , 1978).
Zimmerman and Kaufman (19 77) reported that timolol lowered 
I OP in man with no significant effect on facility of 
outflow. Based on these results the authors suggested that 
timolol lowered lOP by decreasing AH formation. Using 
fluorophotometry several workers have found that timolol 
decreases AH formation in the human normotensive and 
hypertensive human eye while outflow remains unaltered 
(Coakes and Brubaker, 1978; Yablonski et ^ .  , 1978; Korey et 
al., 1982).
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The effect of timolol on AH formation in the rabbit eye 
was investigated using fluorescein-dextran where the dye was 
infused into the anterior chamber (Miichi and Nagataki, 
1982). In these experiments, timolol had no significant 
effect on either AH formation or lOP. However, using the 
same technique in monkey eye, Miichi and Nagataki (1983) 
have shown that topically applied timolol lowered both I OP 
and AH formation.
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The Involvement of Prostaglandins In The Ocular Hypotensive
Response To Adrenaline.
It has been reported that the ocular hypotensive 
response to adrenaline declines during continuous treatment 
(Langham and Diggs, 1974) and it has been suggested that 
this tachyphyllaxis to adrenaline was due to negative 
feedback mediated by PCs. To test this theory,
Bhattacherjee and Hammond (1977) investigated the effect of 
indomethacin on the hypotensive response of the rabbit eye 
to topically administered adrenaline. Indomethacin is a 
cyclo-oxygenase inhibitor and therefore inhibits PG 
synthesis. Although a 2% solution of adrenaline
administered twice daily for twenty one days lowered lOP, no 
tachyphyllaxis was observed. However, pretreatment with 
indomethacin (0.125% or 0.25%) inhibited the ocular 
hypotensive response to adrenaline. Although this
antagonism appeared to be fully effective after two days of 
pretreatment, there was considerable variation. If 
adrenaline does release PGs which antagonise the hypotensive 
response to adrenaline then inhibition of PG production by 
indomethacin, should potentiate the hypotensive response to 
adrenaline. Since indomethacin antagonised the hypotensive 
response to adrenaline, it appears that any PGs released by 
adrenaline in fact lowered lOP directly or facilitated the 
effect of adrenaline. This possibility is perhaps not so 
surprising considering that PGs can lower lOP (Starr, 1971; 
Camras et ^ .  , 1977; Weizmann et ^ .  , 1982 and Hoyng,. 1984).
The ocular responses to PGs and the possible mechanisms 
involved will now be described in greater detail.
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In addition to their well-known ocular hypertensive 
effect, PGs can also produce a significant and prolonged 
reduction in lOP, which can be preceded by a rise in lOP. 
(Starr, 1971; Camras et , 1977; Weizmann e^ , 1982; 
Hoyng, 1984). In man, monkey and rabbit this response is a 
dose-related phenomenon.
Topical or intravitreal injections of PGEg (10 to 25ng) 
or PGF^g^a (50 to 200ng) produced a biphasic I OP response in 
the rabbit eye; a relatively short initial hypertensive 
phase followed by a prolonged hypotensive phase ( Camras et 
al. , 1977). However, low doses of PGF^^a (1 to 5ng)
produced prolonged hypotension without any prior rise in 
lOP. With such low doses, the hypotensive response was 
maximal within five hours and over within fifteen hours, 
whereas with higher doses the hypotensive response was not 
apparent until five hours after
PG administration, was maximal within ten hours and was 
still apparent after 24 hours.
In a majority of experiments investigating the ocular 
effects of PGs, lOP was not monitored for such a lengthy 
time and this may explain why this hypotensive response is 
poorly documented. In a separate series of experiments, low 
concentrations of PGE, (0.2 to 0.8ng) injected intravenously 
or intracamerally, produced the expected rise in lOP. 
However, in 25% of the animals studied lOP continued to fall 
below control levels and remained depressed for at least 
three hours (Starr ^  , 1971).
It has been suggested that these opposing hypertensive 
and hypotensive responses may run concurrently and that the 
depressor phase only becomes evident after the strong 
pressor phase has worn off.
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The Ocular Responses To Prostaglandins.
The effects of prostaglandins (PGs) on the eye have 
been the subject of extensive studies in recent years.
In the rabbit eye, PGs of the E and F type can increase 
and decrease lOP, whereas PGA 2  has very little effect on 
lOP.
Topical or intravitreal injection of several PGs (0.1 
to lOnc), including PGE^, PGF'2 ^ 1 6-keto PGF^^ and
prostacyclin (PGI2 ) produced a dose-dependent increase in 
lOP (Camras et aj^ . , 1977; Vvaitzman et al. , 1979 ; Golubovic
and Radmanovic, 1982; Kulkarni and Srinivasan, 1982). This 
rise was apparent within ten to thirty minutes and lasted 
for approximately two hours. Similarly, the stable PG
endoperox ide, 1346619 , also increased lOP. The PG antagonist 
N0164 had no effect on lOP but prevented the rise in IÜP 
produced by PGE 2  and U46619 (Kulkarni and Srinivasan, 1982).
Arachidonic acid, the precursor of the PG endoperoxides, 
produced a rise in I OP following its infusion into the 
arterially-perfused enucleated cat eye. Indomethacin
pretreatment did not alter this response (van Alphen 1981, 
1982).
However, indomethacin did antagonise the hypertensive 
response to both topical and intravitreal injections of PGE 2  
(Camras et al. , 1977). Polyphloretin phosphate, a PG
antagonist, blocked the rise in IOP following treatment with 
PGE^ (Starr, 1971).
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These results suggested that following the application of 
exogenous PGs, either these, or endogenous PGs synthesised 
de-novo, act directly at a site within the eye to increase 
lOP.
Using a combination of suction cup and constant 
pressure perfusion to calculate AH inflow and pseudofacility 
and constant pressure perfusion to measure outflow 
facility, Masuda and Mishima (1973) examined the effects of 
injected PGs on AH dynamics in the rabbit eye. Both PGE^^ 
and PGEg produced a dose-dependent rise in AH formation 
which lasted for approximately three hours; while 
pseudofacility was increased true outflow facility was 
unaltered.
Similarly, using the constant pressure perfusion 
technique. Green and Kim (19 85) showed that although TOP 
increased following topical application or the infusion of 
PGE^, or PGEg, total outflow was unchanged. By infusing the 
anterior chamber with fluorescein-dextran, Miichi and 
Nagataki (1982) also showed a rise in pseudofacility one and 
a half hours after the administration of high doses of PGFg 
a It has, therefore, been suggested that the rise in total 
outflow facility observed during PG-induced ocular 
hypertension was in turn due to a breakdown of the 
blood-aqueous barrier. This rise in pseudofacility could be 
caused by the vasodilatory effect of PGs.
Topically applied PGs cause marked vasodilation 
concurrent with an increased vascular permeability 
(Whitelocke and Eakins, 1973). Vasodilation would cause a 
change primarily in capillary pressure and hence vascular 
permeability, due to an increase in vessel diameter.
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This increase in capillary pressure would force more fluid 
out of the capillaries, thereby increasing ultrafiltration.
A breakdown of the blood aqueous barrier is reflected in the 
increased protein levels found in the AH following PG 
administration (Kass et a].., 1972; Camras e_t ajL. , 1977;
Golubovic and Radmanovic, 1982; Kulkarni and Srinivasan, 
1982). Alternatively or in addition, PGs may stimulate 
active transport across the ciliary body, therefore 
increasing aqueous production. Cole and Nagasubramanian 
(1972) found that PGE^ increases transepithelial 
short-circuit current in isolated ciliary body preparations.
This is thought to indicate increased active transport.
Although PGIg is a major product of AA metabolism it is 
an unstable compound (with a half-life of 10 minutes) which 
readily breaks down into the stable compound 6-keto P G F ^  
Recently, it has been shown that both the iris-ciliary body 
and conjunctiva of the rabbit eye possess the ability to 
synthesise PGIg ( Bhattacher jee et ^ .  , 1979).
Intravenous infusion of PGIg lowered lOP in a 
dose-dependent fashion (Weizmann e^ al. , 1982). Low doses 
of PGIg (20 to 70ng.min ^ ) rapidly lowered lOP, whereas 
higher doses (lOOng min ^ ) raised lOP.
Since PGI 2  tends to be rapidly inactivated in air, the 
IOP responses to topically applied PGIg are unpredictable. 
Nonetheless, Hoyng (1984) has investigated the effect of 
topically applied PGIg on lOP. Low doses of PGIg (5ng) 
lowered lOP after one hour, with a rapid return to control 
values within six hours. Three consecutive doses of 5ng of 
PGI 2  reduced lOP for at least four hours. In both cases no 
hypertensive phase was apparent. Topically applied 6-keto
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PGF^^a (250ng) produced only a transient rise in IOP whereas 
250ng of PGIg produced an initial rise followed by a fall in 
lOP. Although these results suggest that the PGIg-induced 
hypotension is produced by PGI 2  itself and not by its stable 
end-product, it would be of interest to study the effect of 
low doses of 6-keto PGF^^^on lOP.
In the rabbit eye there is a very narrow margin between 
the doses of PGs which produce only ocular hypotension and 
those which cause both hypotension and hypertension. This 
appears not to be the case in cat and monkey eyes. Topical 
application of very high doses of PGF^^^a and PGEg caused a 
long lasting fall in lOP with negligible breakdown of the 
blood-aqueous barrier (Camras and Bito, 1981; Stern and 
Bito, 1982). In the cat eye, topical application of up to 
SOOng of PGEg or PGF^^a lowered IOP with a maximum reduction 
occurring between one and eight hours after PG 
administration. Indomethacin pretreatment had no effect on 
these hypotensive responses. This hypotension was not 
preceded by an initial hypertensive phase. Similarly in 
rhesus monkey eyes, topical application of 100 or SOOng of 
PGEg or PBFg ^  respectively, produced a fall in I OP within 
two hours which was preceded by an insignificant rise in 
lOP.
The sequence of events leading to this PG-induced 
hypotony remains obscure.
Unlike the hypertensive responses to PGs, this 
hypotensive response cannot be accounted for by a maintained 
breakdown of the blood-aqueous barrier. Following the rise 
in lOP and AH protein levels, AH protein levels returned to 
normal during the fall in lOP. (Camras et ^ .  , 1977).
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The fact that a significant increase in I OP resulted when a 
second dose of PGEg was applied to the eye during the 
hypotensive phase also suggests that the blood-aqueous 
barrier was functional (Beitch and Eakins, 1969). During 
the hypertensive response PGs produce vasodilation of ocular 
blood vessels (Whitelocke, 1973; Wizemann et , 1982);
however, following intravenous infusion of 20ng.min ^ of 
PGIg, which lowered lOP, the luminal diameters of vessels of 
the posterior uvea were unaltered (Wizemann et a^,, 1982).
Associated with the fall in lOP produced by topically 
applied or intravi treally injected PGEg or PGF 2 Q(^was a 
reduction in outflow resistance in either the anaesthetised 
or freshly killed rabbit (Camras et ^ .  , 1977). This effect 
could not be attributed to pseudofacility nor alterations in 
secretory mechanisms since the secretory mechanism returned 
to normal levels during maximal hypotony.
Since small amounts of PG activity could be detected in 
the AH by either immunoassay or bioassay six to eighteen 
hours after topical PG application, it is possible that the 
hypotensive phase may result from the continual presence of 
PGs in the eye.
It is also possible that the prolonged hypotonic 
effects of PGs is due to the accumulation of a second 
messenger. PGs are known to exert their effects in many 
biological systems by altering intracellular levels of cAMP 
PGs have been shown to increase the cAMP content of 
several ocular tissues vitro including the
sclero-trabecular ring, iris-ciliary body and cornea 
(Neuf eld et ^ .  , 1972; Neuf eld and Sears, 1974) and
intracameral injections of cAMP have been shown to increase
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outflow facility in the rabbit eye (Neufeld et , 1975; 
Neufeld and Sears, 1975). Therefore, following exogenous PG 
administration, the prolonged residual levels of PGs may 
increase the cAMP content of intraocular tissues and fluids 
which in turn may account for the long-term increase in 
outflow facility.
The possibility that PG-induced hypotension depends on 
the de-novo synthesis of PGs or other cyclo-oxygenase 
products has also been ruled out, because the hypotensive 
phase was not abolished by systemic pretreatment with 
indomethacin (Camras et , 19 77) .
It is also unlikely that the lOP-lowering effect of PGs 
is related to sympathetic activity or to the release of 
endogenous catecholamines, since the time-course of the lOP 
response was very similar in both normally innervated and 
sympathetically denervated eyes. In fact, the only
difference was a faster transition from the hypertensive 
phase to the hypotensive phase in the denervated eye (Camras 
et al., 1977).
Other Properties Of Indomethacin.
Indomethacin as a calcium antagonist.
Indomethacin, while a prototype inhibitor of 
cyclo-oxygenase, is known to have other pharmacological 
effects, one of which is inhibition of calcium movements 
(Northover, 1972,1977,1982).
Calcium has been implicated in alpha and beta receptor- 
mediated contraction, relaxation and metabolic effects on
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vascular and other smooth muscle. (Fitzpatrick et aJ.. , 1972; 
Wauah, 1972; Anderson, 1973).
The relaxing and metabolic effects in smooth muscle
mediated by beta-receptors are related to an increased cAMP
level, which in turn, stimulates an energy-dependent, 
calcium-binding mechanism, which probably decreases
myoplasmic calcium. A reduction in cAMP levels due to alpha 
receptor stimulation results in the release of bound calcium 
(Anderson, 1972). In ocular tissues, topical NA, adrenaline 
and isoprenaline increase the cAMP content of the AH and
ocular tissues (Neufeld et , 1972; Neufeld and Sears,
1974). It is this cAMP which is believed to be responsible 
for the hypotensive action of adrenaline. Since calcium is 
involved in cAMP-mediated responses, in this case ocular
hypotension, then release or binding of intracellular
calcium is likely to affect the hypotensive response to 
adrenaline. Indomethacin has been reported to inhibit the
uptake of calcium by cell membranes of various tissues and
to inhibit the depolarization of vascular endothelial cells 
(Northover, 1977). Similar inhibition by indomethacin of 
calcium binding in ocular tissues may have affected the 
ocular responses to adrenaline. Recently, a new class of 
non-steroidal anti-inflammatory drug, the oxicams, has been 
developed. Piroxicam, a member of this class , appears to 
be an ideal drug to study the effects of PG inhibition on 
the ocular responses to adrenaline. In contrast with 
indomethacin, not only is piroxicam a more potent inhibitor 
of PG synthesis but at concentrations vastly greater than 
those which inhibit PG synthesis, it has no effect on 
calcium fluxes (Burche et al., 1983).
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Inhibition Of Phosphodiestase By Indomethacin.
Indomethacin is also an inhibitor of phosphodiesterase 
(Flores and Sharp, 1972; Hall and O'Regan, 1975). If there 
were an inhibition of phosphodiesterase activity, then the 
increased levels of CAMP would, if anything, have enhanced 
the effect of adrenaline in lowering lOP.
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AIM OF RESEARCH
In the rabbit eye adrenaline can produce either ocular 
hypertension and/or hypotension depending upon the dose, 
frequency and route of administration of the drug. Broadly, 
this research set out to study the mechanism of the hypotensive 
response to adrenaline with particular reference to its 
inhibition by indomethacin.
Initial experiments in the conscious rabbit attempted to 
confirm the type, magnitude and duration of the pressure 
responses to topically applied adrenaline and to establish a 
control pattern against which inhibition by other drugs was to 
be detected.
Since this hypotensive response to adrenaline is thought to 
result from an increased facility of outflow of aqueous humour, 
this parameter would be measured in anaesthetised rabbits and 
the time course of the effect determined.
Although indomethacin has been shown by others to block the 
hypotensive response to chronic adrenaline treatment in 
conscious rabbits, it would be necessary first to show that such 
inhibition also occurred following acute dosage with adrenaline.
Pretreatment of such animals with indomethacin would then 
indicate whether this drug's blockade of the adrenaline induced 
hypotension was exerted at the level of facility of outflow.
Further definition of the mechanism whereby indomethacin 
inhibits the responses to adrenaline might then be acquired by 
substituting indomethacin with other cyclo-oxygenase inhibitors, 
such as piroxicam or aspirin, whose subsidiary properties differ 
from those of indomethacin. Since these other properties of 
indomethacin include calcium channel blockade, testing verapamil 
might indicate whether such activity could explain 
indomethacin's ability to block the adrenaline effect.
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The use of timolol should confirm whether the effect of 
adrenaline on facility of outflow is mediated via beta 
adrenoceptors.
If the experimental evidence suggests that the responses to 
adrenaline are inhibited by indomethacin because of cyclo 
oxygenase blockade, then more definitive information might be 
available by measuring PG concentrations in the aqueous 
humour following adrenaline treatment with or without indometh - 
acin pretreatment.
Since topical adrenaline raises the levels of cAMP in the 
aqueous humour, the present experiments will attempt to confirm 
whether indomethacin can indeed block the cAMP-induced rise in 
facility of outflow in the rabbit eye. Such experiments should 
perhaps help to trace any link which exists between cAMP and PGs 
in the responses of the outflow tissues.
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MATERIALS AND METHODS
Measurement of Intraocular Pressure
lOP can be measured directly by manometric techniques or 
indirectly by tonometric techniques.
Manometric measurement of lOP involves the insertion of a 
needle into the anterior chamber of the eye. During this 
procedure the rabbit is under general anaesthesia. A major 
drawback of this technique is that cannulation of the eye and 
the prolonged presence of the needle within the chamber can 
damage the eye. The indirect method involves measurement of 
pressure by indentation or applanation of the cornea. In these 
studies applanation tonometry was used. This method measures 
the force required to flatten an area of the cornea as an index 
of pressure in the eye. This procedure requires only local 
anaesthesia. The applanation tonometer requires careful
calibration and it should be remembered that there are 
dissimilarities in the elasticity of the cornea between 
different species.
Tonometric Measurement of Intraocular Pressure
Before being used in any experiment Dutch rabbits (1.5 to 
3.5 kg) of either sex were acclimated to laboratory conditions 
for several weeks.
On the morning of each experiment rabbits were restrained by 
placing them in close-fitting canvas bags. The animals were 
then left to settle for at least 15 min.
Following topical anaesthesia with 50jil of a 0.5% solution 
of benoxinate hydrochloride, lOP measurements in the conscious 
rabbit were taken with a Digilab Pneumatonometer calibrated on 
the cannulated rabbit eye.
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Five applanations of the cornea with the pneumatic floating 
tip were made for each measurement and an average taken. To 
avoid any unnecessary pressure to the eye, great care was taken 
to gently pull back the eyelid when reading lOP.
Usually two control measurements of lOP, 15 min apart, were 
taken prior to drug application. All drugs were slowly dropped 
over the surface of the cornea from a micropipette. A constant 
volume of 50jil of each drug was administered. Following drug 
administration, lOP was measured at hourly intervals for at 
least 4h.
Since repeated application of local anaesthetic to the eye 
appeared to cause corneal drying, each population of rabbits was 
left for 2 to 3 days before being used in another experiment.
Calibration of the Digilab pneumatonometer
The Digilab pneumatonometer is a device normally used to 
measure lOP in the human eye. Since the curvature and 
elasticity of the human cornea differs from that of the rabbit, 
the pneumatonometer has to be recalibrated in order to 
compensate for this.
Dutch rabbits were killed by an overdose of sodium 
pentobarbitone (approx. 500mg) injected into the marginal ear 
vein. The anterior chamber of the eye was then cannulated with 
the aid of a needle gun. The cannula consists of a 30G needle 
attached to a length of nylon tubing (Portex; 0.25mm bore, wall 
thickness 0.25mm). The cannula was connected to a manometer via 
a 3-way stopcock. To ensure that no air bubbles were introduced 
into the system during cannulation, mock aqueous humour was 
allowed to flow through the needle from the reservoir whilst 
cannulating the eye.
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The pressure in the system was raised to 3OmmHg by raising 
the reservoir 408mm above the level of the needle in the 
anterior chamber. The pressure was allowed to equilibrate for 5 
min and 5 readings of lOP were made using the pneumatonometer.
A further 3 min were allowed to pass and a second set of five 
readings were taken. This procedure was repeated until there 
was no substantial difference between the two sets of readings, 
i.e. no greater than 0.4mmHg between consecutive sets of 
readings. The manometer pressure was lowered by SmmHg 
increments and the procedure repeated until a pressure of SmmHg 
was reached. This procedure was carried out simultaneously in 
the contralateral eye.
Having plotted manometric pressure against the tonometer 
readings, regresion analysis was used to calculate the slope(S) 
and the intercept (I) of the line. The relationship between 
tonometer reading(T) and lOP may be expressed as follows.
lOP (mm Hg) = T - I
Following each measurement of lOP, pupil diameters (PD) were 
measured visually under uniform artificial illumination with a 
transparent millimeter ruler, held horizontally.
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In Vivo Measurement of Facility of Outflow of Aqueous Humour in 
the Perfused Rabbit Eye.
In these experiments the main aim was to measure the 
facility of outflow of aqueous humour i.e. the ease with which 
aqueous humour can leave the anterior chamber. Secondary to 
outflow measurements, lOP was continuously recorded throughout 
the course of the experiment.
Dutch rabbits (1.5 to 3.5 kg) of either sex were
anaesthetised with a 25% solution (w/v, in water) of urethane
(ethylcarbamate). Urethane solution (approx. 6ml kg ^ body 
weight) was slowly infused, via a polythene catheter (0/D 0.75mm 
Portex), into the marginal ear vein until the animal showed no 
corneal reflex. A tracheal cannula was then inserted to ensure 
that respiration was not impaired by nasopharyngeal mucus, which 
is usually secreted under urethane anaesthesia. In some animals 
the femoral artery was cannulated with a polythene catheter (0/D 
0.75mm Portex). By attaching this catheter to a Gould pressure
transducer (model P23ID) which was then attached to a polygraph, 
arterial blood pressure was recorded. The animals were then 
laid prone in a restrainer box designed to hold the head steady.
A diagrammatic representation of the apparatus used to
determine facility of outflow is illustrated in Fig.( 1 ).
Using a needle gun (Edwards and Yerlett,1972) a single 
perfusion needle (30G hubless 0.5" blade: NI medical) was
inserted into the anterior chamber of each eye. The needle was 
inserted tangentially to ensure a firm seal and to avoid 
touching the iris or lens during or after insertion. Attached 
to the needle was silicon-rubber tubing (bore 0.5mm, wall 
thickness 0.25mm: Esco Rubber Ltd.) and then polythene tubing
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reservoir
intraocular 
perfusion -
pressure ^  
transducer
intraocular injection
polygraph
Fig. 1 Diagram of the apparatus used to measure the 
apparent facility of outflow and lOP in the anaesthetised 
rabbit.
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(Portex Ltd) which connected it to a 3-way stopcock (Henleys 
Medical Supplies).
The stopcock was in turn connected to a polythene reservoir 
and a Gould pressure transducer (model P23ID). The reservoir 
was hung on the arm of a Gallenkamp torsion balance (fullscale 
deflection lOOOmg) which stood upon a labjack of adjustable 
height.
The reservoir, tubing and pressure transducer were filled
with an aqueous humour substitute (AHS) of the following
composition ( Barany, 1964).
NaCl llOmM
KCl 3.0mM
CaClg 1.4mM
MgClg.GHgO O.SmM
KgHPOj 0.9mM
NaHCO] 30mM
Glucose 6.OmM
Ascorbic Acid l.OmM
-1
Heparin 20 lU ml
The labjack allowed the reservoir to be adjusted to a height 
which exerted a known pressure greater than resting lOP. By 
connecting the pressure transducer to a Grass polygraph recorder 
(model 7) a continuous record of TOP was obtained.
The resistance of this system was checked visually by 
ensuring that the flow of AHS from the needle was far greater 
than the rate at which AHS could possibly be required to perfuse 
the eye.
If the stopcock is opened from the reservoir to the eye and 
a known pressure applied, then fluid runs from the reservoir
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into the eye and forces an equal volume of aqueous humour to 
drain through the meshwork (assuming there is no compliance by 
the eye). Knowing this volume of fluid and the applied pressure 
required to force it through the meshwork, the facility of 
outflow (C) of aqueous humour can be calculated as follows.
C (jjl.min. ^mm ^Hg)= ouflow (jjl.min  ^)
Papp “5)
Where is equal to the additional pressure applied by the
reservoir. (For a worked example and analysis of precision, 
see Appendix IV.)
The outflow or volume of fluid lost from the reservoir is 
measured on the balance as its weight in mg, assuming a density 
of Ig.ml ^.
The applied pressure was set 4mmHg above ambient lOP by 
raising the height of the reservoir while monitoring TOP changes 
on the polygraph. A typical polygraph trace of the pressure 
within the anterior chamber is shown in Fig. ( 2 ).
When the stopcock is opened to the eye, perfusion begins. 
During the first minute of perfusion, lOP rapidly rises to the 
applied pressure (usually within 10-15s) and some compliance of 
the eye may occur. After one min, perfusion has reached steady 
state during which it can be assumed that each jjl leaving the 
reservoir causes 1^1 to drain from the anterior chamber. An 
average of 3 one-min readings of the balance during steady state 
perfusion were used to calculate C. Such determinations of 
facility of overflow were carried out at 30 min intervals for a 
period of 2.5h.
Before each determination of facility of outflow, PDs were 
measured horizontally under standard illumination using calipers 
with a vernier scale 68
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Measurement of the Prostaglandin Concentration in the Aqueous 
Humour Using Radioimmunoassay.
The sensitivity and specificity of radioimmunoassay (RIA),
allows us to accurately measure very small concentrations 
— 6 — Q(10 -10 g) of PGs in the aqueous humour.
RIA is based on an antigen-antibody reaction. This reaction 
depends on the formation of weak bonds that can be readily 
dissociated, so one antigen molecule can be displaced by 
another.
If a radiolabelled antigen is used to form an antigen-antibody
complex and then a further unknown amount of the same, but
unlabelled antigen is added, some of the radiolabelled antigen
will be displaced. Once equilibrium has been obtained the
percentage of total label which is bound is inversely
proportional to the concentration of unlabelled antigen (i.e.
the substance to be measured).
The concentration of antibody to be used in the RIA, in this
case antibodies against PGE 2  and 6 keto PGF^raised in horses is
calculated using an antibody titer. A working definition of
titer is "that dilution of antibody which binds a specified
percentage of a standard amount of radiolabelled antigen", in 
3 3this case ( H) PGEg or ( H) 6 keto PGF^, under set conditions. 
However, the percentage binding required is restricted to a 
certain range by two factors, the precision and sensitivity 
required of the assay. Precision is a term which explains the 
amount of variation in the estimation of unlabelled ligand 
whereas sensitivity refers to the theoretically smallest 
quantity detectable.
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As the percentage bound decreases, sensitivity increases 
whereas precision decreases; the opposite is true as the
percentage bound increases. Therefore the best balance between 
sensitivity and precision occurs when 30 to 50% of the antigen 
is bound. The appropriate antibody titers for PGEg and 6 keto 
PGF^g^ were estimated by incubating various dilutions of the 
antibody (1/500 to 1/10,000) with a fixed amount of
radiolabelled PG ( 45nCi) under set conditions. The total
amount of PG bound by the antibody was calculated by including a
sample containing no exogenous PG ie lOOjil of antibody plus up 
to 200jal of RIA buffer.
Radioimmunoassay of PGEg and 6-keto PGF^^
This assay is a modified version method of Sors et ^ . , 1978.
Volumes up to 200^1 of AH were placed in plastic Eppendorf 
tubes (1.5ml) and 10 0^1 of the appropriate antibody dilution was
added followed by volumes up to 200ul (45nCi,0.25 fmol) of (^H)
PG. These samples were mixed and incubated for 24h at 4^C. 
Following incubation, lOOjil of ice-cold dextran-coated charcoal 
was added. This porous charcoal readily takes up small 
molecules thereby separating unbound radiolabelled PG from the 
larger protein-bound complex. The reaction was stopped by 
placing the samples on ice. These samples were spun at 3,500xg 
for 5 min at 5°C in a Damon/IEC centrifuge. 200jil of the 
resultant supernatant was transferred to plastic vials 
containing 10ml of scintillant (Packard).
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Radioactivity was then counted in a Tricarb Liquid 
Scintillation Spectrometer for 5 min. Activity of
non-specifically bound radiolabelled PGs was calculated by 
including samples which contained no antibody, ie 200|il of 
aqueous humour and lOOjil of RIA buffer. For the composition of 
both the RIA buffer and dextran-coated charcoal solution see 
Appendix I.
A series of standards containing known amounts of PGs (O.lpg 
to 3ng) dissolved in RIA buffer, were used to construct a 
standard curve from which the concentration of PG in test 
samples could be calculated.
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Extraction and Concentration of PGs from the AH.
It proved impossible to improve the sensitivity of the assay 
enough to measure endogenous PGs in the AH by adjusting the 
antibody titer or (^H) PG concentration. Therefore the amount 
of PG to be assayed was increased by pooling and then extracting 
and concentrating AH from several rabbits.
Approximately 150|il of AH was withdrawn from each eye (control 
or drug-treated) using a syringe fitted with a 26G needle. 
These samples were pooled and the pH adjusted to 3 using O.IM 
citric acid. 1ml aliquotes were taken through the following 
extraction procedure. 3ml of a cyclohexane-ethylacetate mixture 
(1:1 v/v) was added to each sample which was mixed for Imin and 
spun in a Damon/IEC centrifuge at 300xg at 0°C for 5min. The 
organic solvent layer was carefully removed using a Pasteur 
pipette. This procedure was carried out 5 times in total. 
Pooled solvent samples in glass tubes were placed in a heated 
metal block at 40°C and concentrated by blowing down the sample 
under a stream of ^ 2  (O2  free).
The dried sample was reconstituted in a volume of 200pl, 
consisting of 160^1 of RIA and 40^1 of 0.28mM Na2C0g solution. 
This 200^1 sample was then assayed for 6 keto-PGF^
The efficiency of this extraction procedure was estimated by 
adding lOOpl of (^H) 6 keto-PGF^^ (containing 45nCi ) to a 900^1 
sample of either 0.9% saline or AH and counting the 
radioactivity in samples of the solvent following extraction.
The percentage recovery of PG after both the extraction and 
concentration procedure was estimated by adding a known amount 
of 6 keto-PGF^^(100^1) to a 900ul sample of either 0.9% saline 
or AH.
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In some instances in this series of experiments a white 
flocculent precipitate formed when the cyclohexane-ethylacetate 
mixture was added to samples of AH. After spinning, this 
precipitate formed a layer between the aqueous and solvent 
phases. Care was taken not to remove any of this layer when 
removing the solvent phase.
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Protein Determination
The assay used for protein determination was based upon the 
method of Lowry, Rosebrough, Farr and Randall (1951), as 
modified by McKean (1982).
Aliquots of aqueous humour were made up to a lOOjil volume 
with N-sodium hydroxide solution. A standard curve was prepared 
for each batch of samples by assaying a series of bovine serum 
albumin standards (0 to 50pg) made up in distilled water and
diluted to lOOjal with N-sodium hydroxide. 1ml of solution C 
(Appendix I) was added to each test or standard sample at
staggered time-intervals and mixed.
After 15 min, lOOjil of N Folin-Ciocalteu reagent was added 
to each sample. The solutions were mixed immediately and 
allowed to stand at room temperature for 30 min before the
measurement of their extinction at 750nm on either a Cecil
grating spectrophotometer (model CE303) or a Shimadzu u.v. 
visible recording spectrophotometer (model u.v.240). Distilled 
water was used as the reference.
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Estimation of Salicylic Acid
Aspirin is rapidly metabolised to salicylate. The time 
course of aspirin absorption and distribution was followed by 
assaying plasma salicylate concentration at 30 min intervals. 
The colour formed by the reaction of salicylate with acidified 
ferric nitrate was used as a measure of plasma salicylate 
concentration.
Following each measurement of outflow facility, approx. 
1.5ml of blood was taken from the femoral artery. The blood was 
placed in plastic Eppendorf tubes (1.5ml) and spun at 10,000xg 
for 3 min in a Quickfit microcentrifuge. 1ml of the resultant 
plasma was mixed with 0.5ml of trichloracetic acid (20%,w/v) and 
spun for 5 min in the microcentrifuge. The supernatant was 
removed using a Pasteur pipette. 0.5ml of protein-free plasma 
was mixed with 3ml of a ferric nitrate solution (see Appendix 
I).
The optical density of these solutions was read at 525nm on 
a Cecil grating spectrophotometer. Distilled water was used as 
the reference.
Salicylic acid samples (0 to 200jig) made up in distilled 
water were assayed and a standard curve constructed.
76
Drug Preparation and Route of Administration
Topical application
The eyelid was gently pulled back and the drug was slowly 
applied to the surface of the cornea from either a "dropper" or 
a Hamilton Microsyringe. A volume of 50yl of each solution was 
usually applied.
Injection
Following the insertion of the perfusion needle, a second 
needle (30 G, hubless, 0.5" blade:- NI medical) was inserted 
into the anterior chamber of the eye. This needle was attached 
to the Hamilton microsyringe via silicone rubber tubing (bore 
0.5mm, wall thickness 0.25mm, Esco Rubber Ltd). Both the 
syringe and tubing were filled with the appropriate drug 
solution. Before injection of the drug solution, the stopcock 
was opened to the reservoir, whose height was adjusted such that 
the pressure it applied equalled ambient lOP. This precluded 
any rise in pressure which would otherwise have occurred during 
intraocular injection. The drug, in a volume not greater than 
10^1 was then slowly (approx. 1^1.min ^) injected into the 
chamber.
Rectal administration
Aspirin suppositories were inserted rectally by hand.
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Drug Preparation 
Adrenaline
The adrenaline solution applied topically to the eye was 
Eppy (Smith and Nephew), a 1% (w/v) solution in an isotonic
buffered ophthalmic solution. Since this vehicle or its 
formulation were unavailable, the control solution used was 0.9% 
(w/v) saline.
Aspirin
Aspirin suppositories were administered rectally (approx. 
200mg.kg ^ ) Ih prior to the insertion of the perfusion needle.
Cyclic nucleotide analogues
8 bromoadenosine 3',5' cyclic monophosphate (8 bromo-cAMP) 
6 2and N , 0 , dibutyryladenosine 3',5* cyclic monophosphate
(d-cAMP) were obtained as the sodium salt. A lOmM solution was 
prepared by dissolving the appropriate weight of each drug in 
distilled water. This solution iSjil) was injected into the 
anterior chamber. Distilled water was used as the vehicle 
control.
Indomethacin
A 0.25% (w/v) solution of indomethacin was prepared in 1.9mM 
NagCOg. The pH of this solution was then adjusted to between 7 
and 8 by slowly adding small volumes of O.lN-NaOH, while 
monitoring the pH on a Metrohm (model E520) pH meter. This 
solution was continuously stirred. 1.9mM solution of NagCO^ was 
used as the vehicle control.
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Piroxicam
A 0.5% (w/v) solution of piroxicam was prepared as
previously described for the indomethacin solution. Since 
piroxicam was prepared in 1.9mM NagCO^ this was used as the 
vehicle control.
Timolol
A 0.25% (w/v) ophathalmic solution of timolol maleate
("Timoptol", M.S.D.) was topically applied to the eye. An 
ophthalmic solution of the timolol vehicle was supplied by Merck 
Sharp and Dohme.
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The Effect Of Topical Application Of Adrenaline On IOP,PD And 
The Apparent Facility Of Outflow Of Aqueous Humour From The 
Anterior Chamber.
The reproducibility of I OP measurements in the concious 
rabbit taken with the tonometer is shown in Fig.3.
The initial I OP measurement is usually higher since it is 
taken when the animals are adjusting to experimental conditions. 
Over a period of 5h there was no significant variation in I OP 
within or between eyes. The latter is particularly important 
since in subsequent experiments only one eye was usually treated 
with the drug.
The effect of topically applied adrenaline on IOP in the 
conscious rabbit is shown in Fig. 4. Unlike most other
experiments the drug treatment (0.25mg adrenaline) was identical 
in both left and right eyes of 10 rabbits. Adrenaline has a 
biphasic effect on lOP, an initial hypertensive phase, followed 
by a longer lasting hypotensive phase. Compared with the
immediate pre-adrenaline reading at -15min, the initial rise in 
lOP (5.2 + 0.2mmHg, P >  0.001) was maximal within Ih, while the 
fall in IOP (4.7 + 0.4mmHg, P ^ 0.001) was maximal within 2h and 
had almost returned to control values 4h following adrenaline 
administration.
The effect of adrenaline on pupil diameter (PD) is also 
shown in Fig.4. As expected adrenaline produced mydriasis. 
This increase in PD of 2.2 + 0.2mm (P ^  0.001) was maximal after 
Ih and remained increased throughout the experiment.
The effects of adrenaline on PD,lOP and facility of 
outflow in the anaesthetised rabbit are shown in Figs 5 and 6 .
Adrenaline (0.5mg) topically applied to both eyes (Fig 5) 
produced the expected fall in lOP and rise in PD.
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Fig. 3 Diagram illustrating the reproducibility of I OP 
measurements taken in the conscious rabbit. Each point 
is a mean + SEM of values obtained in 10 eyes. 81
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Fig. 4 The I OP and PD responses to adrenaline (0.25mg) which 
was topically applied as an aqueous buffered solution to both 
eyes of the conscious rabbit. Each point is a mean + SEM of
values obtained in 10 eves.
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Flg. 5 The effect of topical timolol ( - - A — ) on the facility of 
outflow. I OP and PD responses to topical adrenaline (-o-) in the 
urethane-anaesthetised rabbit. Each point Is a mean + SEM of 
results obtained In 7 eyes. Significant differences between timolol 
treated and vehicle control eyes are shown as *0.05>P)0.01;
**0.01>P>0.001.
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ihe adrena lin e-induc ed rise in ICP seen in the conscious 
rabbit was also seen in the anaesthetised rabbit. However,
although lOP measurement was continuous throughout the 
experiment, the values used to construct the lOP curve are those 
taken immediately prior to each measurement of C. The speed of 
this hypertensive response meant that it was over before the 
first post adrenaline measurement of lOP was taken. The
response was rapid in onset, maximal after apppox. lOmin, and 
complete within 20min. A typical hypertensive response to 
adrenaline is shown in Fig.2. After 1.5h, adrenaline had 
lowered TOP in both eyes (Fig.5). TOP had fallen from 21.4 +
0.7 to 16.5 + 0.9mmHg ( 0. 01"^ P^O. 001 ) , in the adrenaline-timolol
treated eye. Adrenaline also appeared to lower lOP in the 
adrenaline-vehicle-treated eye from 19.9 + 0.7 to 18.5 + 0.6.
However, this fall in TOP was not significant ( 0. l>Pi^O. 05 )
Adrenaline maximally increased PD in both eyes after 1.5h. 
PD had risen from 6.2 + 0.4 to 10.5 + 1.5mm (0.05>P>0.02) in the 
adrenaline and timolol-treated eye and from 5.8 + 0.5 to 9.1 + 
0.4mm (0.Ol^P^O.001) in the adrenaline+vehicle-treated eye.
Of particular importance is the adrenaline-induced rise in 
facility of outflow (Fig.5 ). After 1.5h facility of outflow had 
increased from 0.27 + 0.01 to 0.52 + 0.01 ^l.min  ^ mm ^ Hg 
(P > 0.001) in the adrenaline+vehicle-treated eye and from 
0.27 + 0.01 to 0. 67 + 0.03 ^1 min"^ mm"^ Hg (P> 0.001) in the
adrenaline + timolol-treated eye. The maximal rise of outflow 
facility appears to precede the major fall in TOP following 
adrenaline treatment.
In a separate series of experiments, the effects of 
perfusion alone on TOP and facility of outflow, as well as the 
ocular responses to adrenaline were investigated (Fig.6).
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In these experiments adrenaline (O.Smg) was topically
applied to one eye only, while the contralateral eye received
its vehicle.
Again, after 1.5b adrenaline had increased facility of 
outflow from 0.27 + 0.01 to 0. 56 + 0. 06 pi min  ^ mm ^ Hg (P> 
0.001). After 1.5 h lOP had not significantly changed. However, 
after 2.5 h lOP had fallen from 19.5 + 1.1 to 14.9 + O.SmmHg 
(0.01> P> 0.001).
Topical application of vehicle to the contralateral eye 
(Fig.6) significantly increased facility of outflow and lowered 
lOP. Facility of outflow had increased from 0.26 + 0.01 at
t=0.5h to 0.49 + 0.12 pi min  ^ mm  ^ Hg at t=2.5 h. However,
after 2.5h, facility of outflow was significantly lower (0.05>P^ 
0.01) than facility of outflow seen in the adrenaline-treated 
eye. lOP had fallen from 18.9 + 0.9 at t=0.5 h, to 15.8 + 1mm 
Hg at t=2.5h (0.05^P^0.02). These values were not
significantly different from those in the adrenaline-treated 
eye.
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The Effect Of Topical Timolol Treatment On The Ocular Responses
To Adrenaline In The Anaesthetised Rabbit.
The ocular responses to adrenaline in the presence of
timolol are shown in Figs 5 and 6 . 1.5 h after the application 
of adrenaline (0.5mg) to both eyes, a solution of timolol (25ug)
was topically applied to one eye only (Fig 5).
Timolol had no significant effect on the PD and I OP
responses to adrenaline.
Although Ih after the application of timolol, IGF was still 
significantly lower than the starting ICP, ie at t=0.5h 
(P > 0.001), it did not differ significantly from measurements 
taken Ih after the administration of adrenaline.
Similarly, following timolol treatment, PD remained 
unaltered but was still significantly greater than the original 
PD, ie measurements taken at t=0.5 h (0.01)&P^ 0.001).
After 0.5h and Ih, timolol had partially reversed the
adrenaline-induced rise in facility of outflow (Table 1). These 
values were significantly lower (see table) than those Ih after 
the application of adrenaline. They are also significantly
lower than facility of outflow values measured simultaneously in 
the contralateral eye which received vehicle only (Fig.6).
Fig. 6 again shows the reversal of the adrenaline-induced 
rise in facility of outflow by timolol. Timolol lowers the
facility of outflow from 0.56 + 0.06 at t=1.5 h to 0.33 +
0.04ul min ^ mm  ^ Hg at t=2.5h ( 0.01^ P ^  0.001).
Of similar importance was the failure of timolol to reverse 
the gradual rise in facility of outflow seen during the 
perfusion experiment. Ih after timolol treatment, facility of
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outflow had further increased from 0.34 + 0.03 at t=1.5h to 0.49 
j- 0.12pil min”^ mm“^ Hg at t=2.5h (0.05> P> 0.02)
Although lOP continued to fall in both eyes following 
timolol treatment it was probably not induced by saline or 
adrenaline.
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The Effect Of Indomethacin Pretreatment On The Ocular Responses
To Adrenaline In The Conscious Or The Anaesthetised Rabbit.
In the conscious rabbit topical pretreatment with 
indomethacin (0.125mg) for 30min reduced the hypertensive 
response to adrenaline (0.25mg), Fig 7. In the
indomethacin-treated eye pressure increased from 26.2 + 0.7 at 
t= -0.5 h to 30.3 + 0.6mmHg at t= Ih. Although after Ih TOP was 
significantly higher than I OP at t= -0.5 h and -1.5 h (O.Ol!^ P^ 
0.001 in both cases), it was significantly lower than IOP in the 
contralateral eye which received adrenaline only (0.01 ^  P >  
0.001) .
Of greater importance was the lack of a hypotensive 
response to adrenaline following topical indomethacin 
pretreatment (Fig 7). In the indomethacin + adrenaline-treated 
eye, TOP after 2 and 3h was not significantly different from TOP 
at t= -0.5h and t= -1.5h (0.05 ^ P ^ 0.01 in both cases) .
However, in the absence of indomethacin, adrenaline produced the 
expected fall in TOP. In the vehicle-treated eye, I OP had 
fallen from 26.4 + 0.7 at t= -0.5 h to 24.1 + 0.7mm Hg (0.01>P^ 
0.001) after 2h and to 24.7 + 0.5 ( 0.01^ P ^  0.001) after 3 h.
The PD repsonses to adrenaline were unchanged following 
indomethacin pretreatment. After Ih PD was maximally increased 
in both eyes. In the indomethacin + adrenaline- treated eye, PD 
had increased from 6.9 + 0.1 at t= -0.5h to 9.6 + 0.4mm (O.Oll^P^ 
0.001) in the vehicle-treated eye. After 2,3 and 4 h, PD was 
still significantly higher than control values, ie t= -0.5h 
(0.01> P ^ 0.001 at 2 and 3 h and 0.05>P>0.01 at 4h ).
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Fig. 7 The effect of pretreatment (at -Ih) with indomethacin 
(— A — ) or vehicle (-0-) on the ocular responses to topical 
adrenaline in the conscious rabbit. Each point is a mean + SEM 
of values obtained in 9 eyes. Significant differences between 
indomethacin pretreatment and vehicle control are shown as 
**0.01 >P>0.001.
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Ihe effect of topical indomethacin treatment on the ocular 
responses to adrenaline in the anaesthetised rabbit are shown in 
Fig. 8
Following indomethacin pretreatment (0,125mg), adrenaline 
(O.Smg) failed to lower lOP. After 2h adrenaline had lowered 
lOP from 20.6 + 1.9 (t=0.5 h ) to 13.9 + 0.9mmHg (0.02> P^O.Ol), 
whereas in the adrenaline + indomethacin-treated eye, IOP was 
unaltered (22.1 + 1.9mmHg at t= O.Sh and 19.9 + 0.8mm Hg at
t=2h). At t= 2h, ICP in the indomethacin-treated eye was
significantly higher (0.01 ^ P ^ 0.001) than ICP in the
contralateral eye which received vehicle only.
Of particular importance was the antagonism of the
adrenaline-induced rise in facility of outflow by indomethacin. 
In the absence of indomethacin, adrenaline increases facility of 
outflow from 0.28 + 0.01 at t= O.Sh to 0.67 + 0.08^1 min  ^ mm  ^
Hg at t= 2h ( P > 0.001) but following indomethacin pretreatment 
adrenaline failed to increase facility of outflow which was 0.23 
+ O.Oi^l. min  ^ mm  ^Hg at t= O.Sh ând 0.32 + 0. 04jal min  ^mm ^
Hg at t= 2h. These values were not significantlly different.
In the presence or absence of indomethacin, adrenaline 
produced its expected mydriasis in both eyes. Adrenaline
increased PD from 7.3 + 0.7mm at t= O.Sh to 10.2 + O.Smm at t= 2
h . (p > 0.001) in the adrenaline vehicle-treated eye and from
7.7 + 0.8mm at t= O.Sh to 11.5 + 0.3mm at t= 2h (P > 0.001).
Again PD remained increased for the duration of the experiment.
The effect of indomethacin alone on lOP, PD and the
facility of outflow is shown in Fig.9.
Following the application of indomethacin (0.12Smg) lOP
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Fig. 9 Time course of the ocular effects of topical indomethacin 
in the anaesthetised rabbit. At -30 min drug solution was applied 
to one eye ( —  A — ) and vehicle to the contralateral eye (-0-). 
Each value is a mean ± SEM of values obtained in the number of eyes 
shown. 94
appears to fall from 17.7 + 1.3 mmHg at t= O.Sh to 14.8 + 1 mitiHg 
at t= 2.5h. This fall in pressure was not significant. 
Similarly, following the application of the vehicle, lOP fell 
from 18.2 + 0.8mmHg at t= O.Sh to 14.2 + 0.7mmHg at t= 2.Sh 
(0.0S> P >0.02) .
Topically applied indomethacin (0.12Smg) had no effect on 
the slow but steady rise in facility of outflow which occurs 
spontaneously during the course of a perfusion experiment; 
facility of outflow increases from 0.2S + 0.02 at t= 0 h to 0.39 
+ 0.04^1 min ^ mm ^ Hg at t= 2.S h (0.O S > P > 0.02). A similar 
rise in facility of outflow from 0.28 + O.OS^l min”^ mm~^ Hg at 
t= 2.S h occurred following the application of the vehicle. 
This rise in outflow was not significant. Throughout the 
experiment there was no significant difference between outflow 
values in the indomethacin and vehicle-treated eyes.
After the application of either indomethacin or its vehicle 
to separate eyes, PD remained unaltered during the experiment.
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The Effect Of Verapamil On The IOP And PD Responses To
Adrenaline In The Conscious Rabbit
Topical application of verapamil (O.lmg), or its vehicle to
the rabbit eye had no significant effect on either lOP or PD
over a period of 4h (Fig.10). When the concentration of
verapamil was increased to 0.25mg, verapamil appeared to lower
I OP within Ih and after 2h I OP had fallen from 24.9 + 0.5 to
19.5 + 3.ImmHg (Fig 11). Although verapamil appeared to lower
I OP in the treated and vehicle-treated eye, neither of these
reductions in lOP were statistically significant. However, 
large doses of verapamil (0.5 to Img) produced dose-dependent, 
statistically significant, reductions in TOP in both the treated 
and contralateral untreated eye (data not shown).
The application of verapamil (0.25mg) or its vehicle did 
not alter PD through the course of the experiment.
Since O.lmg of verapamil had no effect on lOP or PD, this 
dose and a very small dose of verapamil (0.05mg) were chosen to 
investigate the ocular responses to adrenaline in the presence 
of verapamil.
Topical application 0.05mg of verapamil had no significant 
effect on I OP or PD, nor did it alter either the pressure 
responses to adrenaline nor the adrenaline-induced mydriasis 
(data not shown). The effect of O.lmg of verapamil on the ICP 
and PD responses to adrenaline are shown in Fig. 12
Although following topical pretreatment with verapamil 
adrenaline increased IOP from 25 + 0.3 to 28.3 + 0.8mm Hg 
(P > 0.01) after Ih, lOP was still significantly lower
(0.01 ^ P ^ 0.001) than I OP in the contalateral eye which
received adrenaline only. IOP had increased from 25.6 + 0 . 5  at
-0.5 to 33.7 + 0.6mm Hg at t=lh (0.01>P> 0.001).
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Fig. 10 The I OP and PD responses to topical verapamil (— A — ) 
or its vehicle ("0-) in the conscious rabbit, Each point is a 
mean + SEM of results in 10 eyes.
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Flg. 11 The effect of topical verapamil (— A — ) or its 
vehicle (-0-) on I OP and PD in the conscious rabbit. Each
value Is a mean + SEM of results obtained in 4 eyes.
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Flg. 12 The effect of pretreatment (at - Ih) with verapamil 
( ~ A — ) or vehicle ( -0-) on the ocular responses to topical 
adrenaline in the conscious rabbit. Each point Is a mean + 
SEM of values obtained In 9 eyes. Significant differences 
between verapamil - and vehicle - pretreated eyes are shown as
*0.05%B>0.01; **0.01>P>0.001.
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o f  greater interest was the failure of verapamil to alter 
the hypotensive response to adrenaline. After 2 and 3h
adrenaline significantly lowered I OP (0.01^ P 0.001 in both 
cases) the verapamil-and vehicle-pretreated eyes.
The adrenaline-induced mydriasis remained unaltered
following verapamil pretreatment.
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The Effect Of Systemic Aspirin Pretreatment On The Ocular
Responses To Adrenaline In The Anaesthetised Rabbit.
Following the systemic administration of aspirin (approx. 
200mg. kg ^ ) the effect of indomethacin (0.125mg) on the ocular 
responses to adrenaline (O.Smg) were investigated. The response 
to these drugs in one population of animals are shown in Fig 13.
In the presence of aspirin, but in the absence of
indomethacin, adrenaline lowered lOP from 17.1 + 0.7 at t= Oh to
13.3 + O.SmmHg at t= 2h (P > 0.001). Following
aspirin-pretreatment in lOP measurements taken in the 
indomethacin + adrenaline-treated eye and the vehicle +
adrenaline-treated eye, the apparent drop in lOP from 16.4 +
O.SmmHg at t= Oh to 14.8 + 0.3mmHg at t= 2h, in the
indomethacin + adrenaline-treated eye was not stastically
significant.
Adrenaline raised facility of outflow from 0.28 + 0.03jal 
min ^ mm ^ Hg at t= O.Sh to 0.60 + 0.07jli1 min  ^ mm ^ Hg (P^ 
0.001) at t= 2h in the absence of indomethacin. Following 
indomethacin pretreatment, facility of outflow was significantly 
lower at t= l.Sh and 2h (O.OS P ^ 0.01 in both cases) in the
indomethacin + adrenaline-treated eye compared to the vehicle + 
adrenaline - treated eye. However, the rise in facility of 
outflow from 0.28 + 0.01 at t= O.Sh to 0.40 + 0.03^1 min ^ mm  ^
Hg at t= 2h in the indomethacin + adrenaline - treated eye was 
significant (0.01> P >0.001).
After aspirin administration, adrenaline significantly 
increased PD in both the indomethacin-and-vehicle-treated eyes
0.001 in both instances).
The above results were obtained in 9 out of 13 animals
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Fig. 13 The effects of systemic aspirin and indomethacin 
pretreatment on the ocular responses to adrenaline in the 
anaesthetised rabbit. Following the systemic administration 
of aspirin (approx. 200 mg kg”b .  indomethacin (— A — ), or 
its vehicle (-0-) were topically applied to the eye at - 3 0 min. 
Adrenaline was then topically applied to both eyes as shown.
Each point represents a mean + SEM of values obtained in 9 eyes. 
Significant differences between indomethacin and vehicle pre­
treatment are shown as *0.05^P^0.01; **0.01^P^O.001.
tested. Because 4 animals showed no response to adrenaline in
either eye, these were grouped together for the purpose of
analysing the results (Fig 14). Adrenaline increased PD in both 
the indomethacin and vehicle-treated eye.
In these animals adrenaline failed to raise facility of
outflow and lower lOP both in the presence and absence of
indomethacin.
In both eyes the starting facility of outflow appeared to be 
abnormally high, but stayed constant throughout the experiment. 
In the vehicle + adrenaline-treated eye, I OP fell significantly 
during the course of the experiment (0.05)^ P ^  0.02), whereas
in the indomethacin + adrenaline-treated eye the fall in IOP was 
not significant.
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Fig. 14 Ocular responses in anaesthetised rabbits to topical 
adrenaline following systemic aspirin pretreatment (approx. 200mg 
k g " b  and topical pretreatment with indomethacin (— A — ) or its 
vehicle (-0-). Each point represents a mean ±  SEM of values 
obtained in the number of eyes shown. ICK!
The Effect OE Piroxicam Pretreatment On The Ocular Responses To
Adrenaline In The Conscious And/Anaesthetised Rabbit.
In the conscious rabbit, topical application of 0.05 mg of 
piroxicam (data not shown) or 0.25 mg of piroxicam (Fig.14) to 
the eye had no significant effect on either the lOP or PD during 
the course of the experiment. Increasing the concentration of 
piroxicam to either 2.5mg (data not shown) or 5 mg (Fig.15) 
produced a dose-dependent fall in lOP in both the treated and 
untreated eyes. Although after Ih the fall in pressure from
26.4 + 0.5 to 22 + 0.6 mm Hg in the piroxicam treated eye was 
statistically significant (0.05^ P ^  0.002) the apparent fall in
pressure in the vehicle-treated eye was not. lOP had returned
to pre-drug values (t= -0.5h) after 2h.
Several different doses of piroxicam (0.05mg to 5mg) had no 
effect on PD.
One hour after the application of piroxicam (0.25mg) to one 
eye only, adrenaline (0.25mg) was then applied to both eyes. 
Fig.16 shows that piroxicam has no effect on the biphasic
pressure response to adrenaline. In both eyes adrenaline
increases lOP after Ih (0.05 ^ P ^ 0.01) and by 2h lOP had 
returned to pre-adrenaline values ie t= -0.5h. After 3 and 4h 
adrenaline had significantly lowered lOP. Pressure had fallen 
from 25.4 + 0.5 at t= -0.5h to 19.5 + 0.4mmHg at t= 3h (0.05 >
P ^ 0.01) in the piroxicam + adrenaline-treated eye and from 
25.1 + 0.5mmHg at t= -0.5h to 19.4 + 0.4mmHg at t= 3h (0.05>P> 
0.01) in the vehicle + adrenaline-treated eye.
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Fig. 15 Ocular response to topical piroxicam in the 
conscious rabbit. At -30 mln drug solution was applied 
to one eye (— A — ) and vehicle to the contralateral eye 
(-0-). Each value Is a mean + SEM of values found In
3 eyes.
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Fig. 16 I OP and PD responses to piroxicam in the conscious
rabbit. At -30 rain drug solution was applied to one eye
only (— A — ) and its yehicle to the contralateral eye (-0-). 
Each yalue is a mean + SEM of values found in 9 eyes.
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Fig. 17 The effect of pretreatment (at - Ih) with piroxicam 
(— A — ) or Its vehicle (-0-) on the ocular responses to topical 
adrenaline in the conscious rabbit. Each point is a mean + SEM 
of values obtained in 8 eyes.
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Again the adrenaline-in duced mydriasis remained unalt ered in 
the presence of piroxicam.
Since piroxicam (0.25mg) failed to inhibit the pressure 
responses to adrenaline, these results indicated that a higher 
dose of piroxicam should be tested. Unfortunately at this 
stage, the tonometric apparatus was no longer available to check 
such a response in conscious rabbits. A higher dose of 
piroxicam was therefore chosen to study the effect of piroxicam 
on the ocular responses, in particular the outflow responses, to 
adrenaline in the anaesthetised rabbit.
The ocular responses to piroxicam (0.75mg) and its vehicle 
in the anaesthetised rabbit are shown in Fig.18.
During the experiment a gradual rise in facility of outflow, 
from 0.24 + 0. 02 at t= 0.5h (0.01 > P > 0.001) to 0.33 +
0.03^1.min.  ^mm  ^ Hg at t= 2.5h (0.01> P ^ 0.001) was seen in 
the vehicle-treated eye. Such a rise in facility of outflow was 
unaltered by piroxicam since a similar rise from 0.24 + 0.02 at 
t= 0.5h to 0. 36 + 0. 0 3|il min  ^ mm  ^ at t= 0.5h (0.01 > P >
0.001), was seen in the piroxicam-treated eye (Fig.17). There 
was no significant difference between facility of outflow in 
both eyes throughout the experiment.
Topical pretreatment with piroxicam (0.75mg) for 30min,
antagonised both the pressure and outflow responses but not the
pupil responses to adrenaline (O.Smg) (Fig.19). In the
vehicle-treated eye, adrenaline raised facility of outflow from
- 1 - 1
0.26 + 0.01 at t= 0.5h to 0.52 + 0.16^1 min mm Hg at t= 2.5h 
(0.01 > p 0.001), whereas in the presence of piroxicam, 
adrenaline failed to raise facility of outflow which was 0.28 + 
0.02^1.m i n . m m ~ ^  Kg at t= 0.5 h and 0.29 + 0.03^1 min  ^ mm~^ 
Hg at t= 2.5h. Compared to the vehicle + adrenaline-treated 
eye, facility of outflow was significantly lower in the 
piroxicam.
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Fig. 18 Time course of the ocular responses to topical pirox 
icam in the anaesthetised rabbit. At -30 min drug solution
was applied to one eye (— A — ) and vehicle to the contra­
lateral eye (-0-). Each point is a mean + SEM of values
obtained in 5 eyes.
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Fig. 19 The effect of pretreatment with piroxicam (— A — ) or 
vehicle (-0-) on the ocular responses to topical adrenaline in 
the anaesthetised rabbit. Each point Is a mean + SEM values 
obtained in 6 eyes. Significant differences between piroxicam- 
pretreatment and vehicle control are shown as *0.05>P>0.01j 
**0.01>P>0.001.
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adrenaline-treated eye at t= 1.5, 2 and 2.5h.
Similarly, adrenaline lowered lOP from 17.2 + 1 at t= 0. 5h 
to 14.7 + O.SmmHg at t= 2.5h (0.05 ^ P ^ 0.02) in the vehicle-
treated eye. It appears that adrenaline has increased lOP in 
both eyes after Ih. Although adrenaline appears to raise I OP in 
the vehicle-treated eye ie from 17.2 + 1 at t= O.Sh, to 19.4 + 
0.7mm Hg at t=lh, this was only verging on significance ie 0.1.^ 
P ^ 0.05. In the piroxicam-treated eye adrenaline significantly 
raises lOP from 16 + 0.9 at t= 0.5h, to 19.9 + 1.2mmHg at t= Ih 
(0.05 P >  0.02) .
However, in the same eye adrenaline had failed to lower lOP 
after 2.5h, at which time pressure was still significantly 
higher (0.05 ^  P 0.02) than pre-adrenaline values, ie t= 0.5h.
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The Effect Of Indomethacin And Piroxicam On The Ocular Responses
To Analogues Of cAMP In The Anaesthetised Rabbit.
The results from this series of experiments are presented in 
a chronological order.
In 1982 Wilson and Campbell.A. reported that indomethacin 
antagonised the outflow responses to dcAMP. Using the 
previously described protocol for measuring facility of outflow 
initial experiments attempted to confirm this report.
The effect of indomethacin pretreatment on the ocular 
responses to dcAMP are shown in Fig 20. In the absence of 
indomethacin, injection of dcAMP (25.5^g) into the anterior 
chamber significantly increased facility of outflow (0.02 P >  
0.01) after 0.5h ie t= Ih. However, the maximal response to 
dcAMP occurred after lh,ie t= 1.5h, at which time facility of 
outflow had increased from 0.27 + 0.04 at t= 0.5h, to 0.60 + 
0.06^1 min ^ mm ^Hg (P > 0.001).
Following pretreatment with indomethacin (0.125mg) injection 
of dcAMP continued to increase facility of outflow (0.05 ^ P ^  
0.02) after 0.5h,ie t= Ih, but again the maximal response was 
apparent after lh,ie t= 1.5h, at which time facility had risen 
from 0.25 + 0.05 at t= 0.5h, to 0.35 + 0.05^1 min"^ mm Hg (0.01> 
P ^ 0.001). Although facility increased following the injection 
of dcAMP, values in the indomethacin + dcAMP-treated eye were 
significantly lower than those in the vehicle + dcAMP-treated 
eye at t= 1, 1.5, 2 and 2.5h.
Although in the vehicle + dcAMP-treated eye, facility of 
outflow increased following the injection of dcAMP, lOP was not 
significantly altered during the experiment.
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Fig. 20 The effect of topical pretreatment (at -30 mln ) 
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to intracamerallv injected dcAMP in the anaesthetised rabbit, 
point represents the mean + SEM of results in 5 eyes. i^ni 
differences between indomethacin - and vehicle - pretreated eyes are 
shown as *0.05>P>0.01j **0.01>P>0.001. i #
Lven in view of the co mparativel y small rise in facility of 
outflow by dcAMP in the indomethacin + dcA^iP-treated eye, lOP 
was significantly lower (0.05 ^  P ^  0.02) after Ih and by 2h
pressure had fallen from 17.9 + O.SmmHg at t= 0.5h, to 14.4 + 
O.SmmHg. At no time were there any significant differences 
between lOP in left and right eyes.
PD was unaffected by either dcAMP or indomethacin.
The responses to dcAMP (25.5 yug) following piroxicam 
(0.75mg)-pretreatment are shown in Fig.21.
In both the vehicle and piroxicarn-treated-eyes facility of 
outflow was significantly higher (0.05 P ^ 0.02 and 0.02 P
0.01, respectively) 0.5h following the injection of dcAMP and
remained higher for the remainder of the experiment. The rise 
was maximal after 1.5h, facility of outflow had increased from 
0.27 + 0.04 at t= 2.5h, to 0.63 + 0.9^1.min.  ^ mm ^ Hg at t=
0.5h, (P>0.001) to 0.58 ^ 0.08^1.min. ^mm ^Hg in the piroxacam- 
treated eye. (P ^ 0.001).
TOP was significantly lowered in both eyes Ih after the 
injection of dcAMP. The peak fall in pressure occurred after 
1.5h, TOP fell from 18.8 + 2 at t= 0.5h, to 14.6 + 2.6mm Hg (P> 
0.001) at t= 2h in the vehicle-treated eye and from 16.2 + 1.4mm 
Kg at t= 0.5h to 12.6 + 1mm Hg (P ^ 0.001) at t= 2h in the
piroxicam-treated eye.
Neither dcAMP nor piroxicam altered PD
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Fig. 21 The effect of topical pretreatment (at -30 mln) with 
piroxicam (— A — ) or its vehicle (-0-) on the ocular responses 
to Intracamerallv injected dcAMP in the anaesthetised rabbit. 
Each point represents the mean + SEM of results from 5 eyes. 
Significant differences between piroxicam and vehlcle-pretreated 
eyes are shown as *0.05>P>0.01j **0.01^P>0.001.
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The ocular responses to injected 8-bromo cAMP in the
anaesthetised rabbit following topical pretreatment with 
piroxicam or its vehicle are shown in Fig.22.
In the vehicle-treated eye 8-bromo cAMP rapidly increases 
facility of outflow. The peak outflow response occurred only 
0.5h after the injection of 8-bromo cAMP, at which time it had 
increased from 0.25 + 0.04 at t= 0.5h, to 0.68 + O.lSyl.min"^. 
mm ^Hg (P > 0.001). Facility of outflow remained significantly
higher than pre-8-bromo cAMP values throughout the experiment. 
Piroxicam pretreatment had no effect on this 8-bromo 
cAMP-induced rise in facility of outflow. Again 8-bromo cAMP 
rapidly raised facility of outflow with a maximal response Ih 
later; outflow had risen from 0.26 + 0.03 at t= O.Sh, to 0.63 + 
O.lOjnl min ^.mm ^ Hg (P > 0.001).
In comparison with the outflow response to dcAMP, the rise 
in facility of outflow produced by 8-bromo cAMP appears to be 
more rapid in its onset.
Accompanying this rise in outflow was a fall in I OP in both
eyes. In the vehicle-treated eye, 8-bromo cAMP produced a
maximal fall in pressure after Ih, ie from 17.5 + 1.5 at t= 
O.Sh, to 13.3 + 1.6mm Hg at t= l.Sh. (P > 0.001). Likewise in 
the piroxicam + dAMP-treated eye, pressure was at its lowest
after l.Sh. lOP had fallen from 15.3 + 2.4 at t= O.Sh, to 11.7 
+ 0.8mm Hg at t= l.Sh (P > 0.001). Although the pressure drop
in both eyes followed a similar pattern, compared to the
vehicle-treated eye,IOP was significantly lower at t= 0, 1 and 
2h, in the piroxicam-treated eye.
Topical application of piroxicam or its vehicle, or the
injection of 8-bromo cAMP,had no effect on PD.
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Fig. 22 The effect of piroxicam on the ocular responses to 
intracamerallv injected 8-bromo-cAMP in the anaesthetised rabbit. 
8-bromo-cAMP was injected into the anterior chamber of each eye 
following topical pretreatment (at -30 min) with piroxicam (— A — ) 
or its vehicle (-0-). Each point represents the mean + SEM of 
values obtained in 6 eyes. Significant differences between 
Piroxicam-and-vehicle-pretreated eyes are shown as *0.05>P>0,01; 
**0.01>B>0.001. 118
The Effect Of The Intraocular Injection Of dcAMP On PD,lOP And
The Apparent Facility Of Outflow In The Anaesthetised Rabbit.
In this experiment dcAMP (25.5jig) was injected into the 
anterior chamber of the eye while its vehicle was injected into 
the contralateral eye. (Fig 23) Although injection of saline 
appeared to increase facility of outflow this rise was only 
statistically significant 1.5 and 2h after the injection. (0.05^ 
P ^  0.02 in both cases). After 2h outflow had increased from 
0.29 + 0.04 at t= O.Sh, to 0.68 + 0.27 y l  min ^ mm ^ Hg. 
However, the outflow responses to injected vehicle were variable 
as indicated by the large standard errors.
Injection of dcAMP rapidly raised facility of outflow. This 
rise was statistically significant after 1, 1.5 and 2h. (P>
0.001 in all cases) This rise was maximal after Ih; outflow had 
increased from 0.29 + 0.05 at t= O.Sh, to 0.81 + O.lSjil min ^ 
mm H^. As a result of the large standard errors in the data 
from the vehicle - treated eye there is no apparent difference 
between outflow values in the vehicle and dcAMP treated eye.
Following the injection of saline, lOP was unaltered in all
but one instance. l.Sh after the injection of saline lOP had
fallen significantly from 15.8 + 2 at t= O.Sh to 11.7 + 1.9mm Hg 
at t= 2h (0.05 ^  P ^  0.02) However, in the dcAMP-treated eye 
I OP was significantly lower after 1.5, 2 and 2.5h. After 2.5h
TOP had fallen from 16.5 + 0.9 at t= O.Sh, to 12.4 + 1mm Hg
(0.05 ^ P ^  0.02) There were no significant differences between 
IOP values in the vehicle- and dcAMP-treated eyes.
As expected injection of dcAMP or its vehicle had no effect on 
PD.
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Fig. 23 The ocular responses to the injection of dcAMP (— A — ) 
or its vehicle (-0-) into the anterior chamber of the anaesthet­
ised rabbit. Each value is a mean + SEM of results obtained in 
4 eyes.
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The Effect Of The Intraocular Injection Of Saline On lOP, PD And
The Apparent Facility Of Outflow In The Anaesthetised Rabbit.
From the aforementioned experiments it appeared that the 
injection of saline into the anterior chamber increased facility 
of outflow. Alternatively, the injection of dcAMP into one eye 
in some way may have produced or altered the response to saline 
in the contralateral eye. Therefore, in the next series of 
experiments facility of outflow was measured before and after 
the injection of 5 jil saline (0.9% w/v) into the anterior 
chamber. Although 2 needles were also inserted into the 
anterior chamber of the contralateral eye saline was not 
injected. Fig.25 shows the results of these experiments.
Although saline was injected into one eye only, facility of 
outflow appeared to rise rapidly and steadily in both eyes 
during the experiment. In the saline-treated and untreated eye 
experimental variation was marked, which is reflected in the
large standard errors. Therefore, in the saline-treated eye,
facility of outflow was not significantly higher until 2h after 
saline injection, at which time outflow had risen from 0.27 + 
0.02 at t= O.Sh, to 0.72 + 0.13 jil min“^ mm”^ Hg (0.02 > P ^  
0.01). Similarly, in the untreated eye the increase in facility 
above starting values became significant at t= 2.5h. At t= 2.5h 
facility had increased from 0.40 + 0.08 to 0.78 + 0.16 J^ l min  ^
mm"^ Hg (0.02 ^ P ^  0.01).
In the untreated eye IOP had not fallen significantly during 
the experiment. However, Ih after the injection of saline lOP 
had decreased (0.01 P ^  0.001). The fall in IOP was maximal
at t= 2.5h, having fallen from 17 + 0.5 at t= O.Sh to 11.4 + 0.7
mm Hg (P > 0.001).
PD was not altered after the injection of saline.
121
10-, Saline
8-
Q
Q.3Q-
16-cn
Q.
O
12 -
'A n=9
o) 0,6—
0,4-
■M
Time (h)
Fig. 24 The ocular responses to intracamerallv injected saline 
In the anaesthetised rabbit. Saline was Injected into the 
anterior chamber (— A — ) via a separate needle which was inserted 
Into each eye at the beginning of the experiment. The contralat­
eral eye was untreated (-0-). Each point represents the mean 
+ SEM of yalues obtained in 9 eyes.
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However, Ih after the injection of saline IOP had decreased 
(0.01]^ P ^ 0.001). The fall in lOP was maximal at t= 2.5h,
having lOP had fallen from 17 + 0.5 at t= O.Sh to 11.4 + 0.7 mm 
Hg (P > 0.001).
PD was not altered after the injection of saline.
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The Effect Of Saline Injection On lOP, PD And The Apparent
Facility Of Outflow In The Anaesthetised Rabbit Following The 
Insertion Of Only A Perfusion Needle Into The Anterior Chamber.
Since trauma to the eye, induced by the insertion of 2 
needles and/or the presence of these needles within the chamber, 
may have been responsible for the varied and apparently 
pathological response of the eye to saline injection, the 
following modifications were made.
Prior to needle insertion, a small metal "T" piece was 
attached to the perfusion needle by silicone rubber tubing. One 
branch of this "T" piece was attached, again using silicone 
rubber tubing, to a Hamilton microsyringe. The second branch
was connected to the perfusion apparatus as previously 
described. This arrangement enabled both injection into and
perfusion of the chamber to be carried out using only 1 needle. 
Fig 24 illustrates the ocular responses to injected saline using 
this apparatus. Following the injection of 5 yl of saline 
(0.9%, w/v) into one eye only, facility of outflow increased and 
IOP fell in both eyes. PD was unaltered.
In the saline-treated and untreated eye facility of outflow 
was significantly greater at t= 1.5h and later, than the
starting value at t= O.Sh. In both cases the rise was
apparently maximal after 2.5h. In the saline-treated eye
facility of outflow had increased from 0.25 + 0.01 at t= O.Sh, 
to 0.65 + 0.08 yl min  ^ mm ^ Hg at t= 2.5h (P > 0.001) and in
the untreated eye from 0.25 + 0.02 at t= O.Sh to 0.70 +
O.lylmin”^ mm”^ Hg at t= 2.5h (P > 0.001).
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Fig. 25 The ocular responses to intracamerallv injected saline 
in the anaesthetised rabbit. Saline was injected via a perfusion 
needle into the anterior chamber of one eye only (— A — ) while 
the contralateral eye (-0-) remained untreated. Each point is a 
mean + SEM of values obtained in 4 eyes.
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similarly, lOP was significantly lower than starting values 
(ie t= 0.5h) at t= 1.5, 2 and 2.5h in both eyes. Although one 
eye was untreated. lOP fell from 17.6 + 0.9 at t= l.Sh, to 12.3 
+ 0.7 mmHg at t= 2.5h (P > 0.001). Following the injection of 
saline, lOP fell from 17.3 + 0.6 to 11.8 + 0.7 mmHg at t= 2.5h 
(P > 0.001).
In these experiments the experimental variation appeared to 
be smaller than that in experiments where 2 needles had been 
inserted into the eye.
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I Eftect Gt' Drug Treatment On AH Protein Concentration
In the non-perfused non-drug-treated ( NPND) eye protein 
1 concentration of the AH was 0. 53 + 0. 03 mg ml~^ (n=15). Ihe
I effect of perfusion as well as drug treatment on AH protein
I concentrations are shown in Table 2 and in all instances,
I protein levels following drug treatment are compared to levels
found in the NPND eyes, as well as to concentrations occurring 
in the aqueous of the contralateral eye within the same 
j experiment. The effect of adrenaline, indomethacin and
piroxicam on AH protein concentrations, coupled with perfusion, 
were also investigated.
The effect of perfusion alone may be seen by comparing the 
j vehicle-pretreated eye in the indomethacin control experiment
' (Table 2, line 1) or the piroxicam control experiment (Table 2
line 5), with the NPND eyes: no significant difference is seen.
If one can assume that pretreatment with NagCO^ solution does 
not prevent aqueous protein from increasing, then perfusion 
! alone does not induce protein entry into the AH. Topically
applied adrenaline (O.Smg) significantly raised the 
concentration of protein in the AH of all the rabbits tested 
(levels of significance shown in table 2), whether pretreated 
with an anti-inflammatory drug or not.
The one exception to this generalisation was that among the 
4 aspirin pretreated animals which failed to show a response to
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adrenaline, protein concentration in the indomethacin-pretreated 
eye was not significantly greater than indomethacin- pretreated 
eyes where no systemic aspirin had been given.
129
The Effect Of The Injection Of Cyclic Nucleotide Analogues On AH 
Protein Concentration Following Pretreatment With Indomethacin 
Or Piroxicam
Injection of solutions into the anterior chamber was 
carried out through a second needle which was inserted into the 
chamber. The effects of these procedures on AH protein
concentrations are shown in Table 3.
Compared to the contralateral untreated eye (whose anterior 
chamber had also been cannulated) intracamerally injected saline 
did not raise AH protein concentrations. Similarly, protein 
concentrations in the AH following the injection of dcAMP (25.5^ 
g) into the anterior chamber were not significantly higher than 
AH protein concentrations following the injection of saline. 
However, in one series of experiments (Table 3 line 3, control) 
injected dcAMP had significantly raised (0.05 ^ P ^ 0.02) the 
concentration of the AH when compared with values found in the 
AH following the injection of saline. (Table 3 line 2, 
control). Topical pretreatment with indomethacin (0.125 mg) 
appeared to suppress this rise in AH protein concentration (0.05> 
P >  0.02). However, the high proteins recorded in the control 
eyes (Table 3 line 3 ) were subject to high variability and
were not corroborated in other similarly treated eyes (Table 
line 2, test and line 4, control); hence, perhaps it would be 
unwise to conclude that dcAMP significantly raises aqueous 
protein or that indomethacin can suppress such an effect. 
Topical pretreatment with piroxicam (0.75 mg) had no effect on 
protein concentrations following the injection of dcAMP or 
8-bromo cAMP (22.4jig)
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Measurement Of AH Prostaglandin Concentrations Using RIA 
Antibody Titer.
It was found that antibody titers of 1/5,000 for PGEg, bound 
approx. 26% and 1/6,000, for 6-keto PGF^^ bound 22% of the 
total amount of PG present. These antibody dilutions were used 
in subsequent experiments, but were later altered to 1/2,000 and 
1/4,000, respectively, in an attempt to improve the sensitivity 
of the assay, but without success.
Standard Curve.
Standard curves for the RIA of known amounts of each PG are 
shown in Figs 26 and 27. These results show that amounts of PG 
greater than lOpg displaced radiolabelled PG from the 
appropriate anitbody in a concentration-dependent fashion but 
concentrations of PGs less than lOpg did not.
Assays Of Endogenous AH Prostaglandins.
Assays of PGs present in samples of rabbit AH up to 200^1 
indicated that the concentrations of PGs present were below the 
sensitivity of the method.
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Extraction And Concentration Of PGs From AH.
The recovery of (^H) 6-keto PGF^from standards extracted in 
cyclohexane-ethylacetate was found to be 63.5% (n=2) on
extraction of saline and 67.5% (n=2) on extraction of AH.
The percentage recovery after extraction and concentration 
was estimated by adding a known amount of 6-keto PGFj^^ (IOOjjI) 
to a 900 ul sample of either saline or AH (an internal 
standard). Following the extraction and drying procedures the 
PG concentration of the reconstituted sample was estimated using 
RIA. In addition, a series of 200^1 samples which had not been 
extracted or dried and which contained a known amount of PG (0 
to lOOOpg) were also assayed. The sample containing no 
exogenous PG represented the maximal concentration of 
radiolabelled PG which the antibody could bind. Results 
obtained from the RIA showed that no PG had been recovered from 
the samples which had been extracted and concentrated, in fact 
in the presence of these samples the antibody appeared to bind 
more labelled PG than the "total-bound" sample which contained 
neither extract nor exogenous PG. Since the dried extracts were 
reconsituted in a solution which contained NagCO^ the effect of 
Na2  COg on binding of PG to the antibody was investigated.
In these experiments, samples containing 10, to lOGOpg of 6-
keto PGF, . were extracted, dried and then reconstituted in 
los
either of 2OOjil RIA buffer or 160 jul of RIA + 40 ^ 1 NagCO^.
Fig. 28 shows that there was no difference in the amount of 
PG bound by the antibody when either of the afore mentioned 
solutions were used. This shows that the prescence of Nag Co^ 
in the reconstituted samples was not responsible for the ability 
of the antibody to bind greater amounts of PG when a
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reconstituted dried extract of AH was assayed using RIA. It 
therfore seemed more likely that the extraction procedure may be 
responsible for this phenomenon. Changing the solvent used to 
extract the PG from the AH from a cyclohexane-ethylacetate 
mixture to ether did not eliminate this problem. Therefore, in 
subsequent experiments, samples of saline containing known 
amounts of PG (10 to lOOOpg) were extracted, dried and the 
reconstituted samples assayed using RIA. Results from these 
experiments indicated that following the aforementioned 
procedures, the ability of the RIA to distinguish between 
relatively high (lOOOpg) and low concentrations (lOpg) was so 
poor that it would be extremely difficult to measure accurately 
any differences in the concentration of PGs in different samples 
of AH.
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Plasma Salicylic Acid Concentrations Following Systemic Aspirin 
Pretreatment.
The concentration of SA in samples of protein-free plasma 
over a period of 3.5h are shown in Fig 29.
At zero time aspirin was administered rectally. After Ih the 
anterior chamber was cannulated and after a further Ih 
adrenaline (O.Smg) was topically applied to the eye.
0.5h after aspirin administration, plasma SA levels had 
risen to 8.17 + 2mg. 100ml ^ . Although SA levels increased to 
13.97 + 1. 5mg. lOOml"^ at t= Ih, they were not significantly
higher than SA levels after 0.5h. However, after 1.5h SA levels 
had risen to 15.45 + 0.96mg.lOOml”^ which were significantly
higher (0.01 ^  P ^ 0.001) than levels found after 0.5h. Peak 
plasma SA levels were found after 2.5h and values remained 
similar for the remainder of the experiment.
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Fig. 29 Plasma salicylate concentrations following systemic 
aspirin pretreatment (approx 200 mg kg”b  at t = 0. Each point 
is the mean + SEM of values found in 5 rabbits.
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DISCUSSION
The IQP Responses to Adrenaline in the Conscious Rabbit.
In the present experiments a single dose of 0.25mg of 
adrenaline applied topically to the rabbit eye produced an 
initial rise followed by a fall in lOP. Using similar
experimental procedures, Innemee and Van Zwieten, (1982)
reported that a dose of adrenaline as low as O.OSmg applied
topically raised lOP by approximately 2mmHg within half an hour, 
although lOP remained elevated after 1 hour. In contrast, other 
workers have reported that although topical application of 0.25 
or 0.5mg of adrenaline lowered lOP, it was not preceded by a 
rise in I OP (Lamble, 1974; Langham and Krieglstein 1976). 
However, in general, although a hypertensive response of similar 
duration has been reported following acute topical
administration of adrenaline (Norton and Viernstein, 1972; 
Lamble, 1976; Rowland and Potter, 1980) the doses required to 
elicit such a response were comparatively much higher (2 to 
lOmg).
It should be noted that under similar experimental 
conditions the pressure responses to adrenaline may differ 
within and between populations of rabbits. Norton and 
Viernstein (1972) reported that only 75% of the rabbit eyes 
tested showed a transitory elevation of lOP following the 
topical application of 4 or 8mg of adrenaline. Similarly, the 
hypertensive response to topically applied adrenaline (2mg) was 
not reproducible between different rabbit populations (Rowland 
and Potter,1980).
Of greater interest in these experiments was the adrenaline 
induced fall in IQP. The ability of adrenaline to produce a
141 a.
dose-dependent fall in lOP has been observed on many occasions, 
not only in rabbit but also in primates and in man (See 
Introduction ) .
Although both the magnitude and the duration of the 
adrenaline-induced hypotensive response in present and previous 
studies are in general very similar a direct comparison cannot 
be made since previous studies used several different 
sub-maximal doses of adrenaline. A direct comparison can be 
made between present results and those obtained by Langham and 
Krieglstein, (1976) who also investigated the lOP and PD 
responses to a single dose of adrenaline (0.25mg) applied 
topically to the eye of the conscious rabbit. Both sets of data 
are in good agreement; in the present experiments, although 
adrenaline produced a maximum fall in lOP of approximately 
5mmHg, lOP remained significantly lower for the remainder of the 
experiment, ie up until 4 hours, Langham and Krieglstein (1976) 
showed that athough adrenaline significantly lowered lOP after 2 
hours the response was maximal after 4 to 5 hours and again 
remained lower for several hours. The maximum fall in lOP was 
approximately 6mmHg. The hypotensive response induced by the 
topical application of O.OSmg of adrenaline (Innemee and Van 
Zwieten, 1982) was extremely similar to the present results in 
both the magnitude and the duration of the hypotensive response. 
Adrenaline lowered lOP by approximately 4mmHg after 2 hours. 
The hypotensive response was maximal between 2 and 5 hours.
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Measurement of Facility of Outflow in The Anaesthetised Rabbit
Before considering the effect of adrenaline on facility of 
outflow it is important to examine the tendency of facility of 
outflow to rise throughout the course of an experiment. In the
present experiments facility of outflow rose steadily over a
period of 2 to 3 hours in vehicle-treated eyes. It is therefore 
particularly important to discuss the factors involved in this 
phenomenon and their relative importance.
When facility of outflow is measured there appear to be 
three main factors which can quantitatively alter facility of 
outflow; a) the "washout" effect b) pseudofacility and c) 
trauma.
a ) The "washout" effect
Perfusion of the anterior chamber can lead to a slow 
increase in the apparent facility of outflow, the so-called 
"washout effect". This washout effect is generally recognised 
as representing the removal of some coating substance from the 
trabecular fibres of the filtration angle.
In the present study the effect of perfusion on facility of
outflow is seen in experiments where only the vehicle was
applied to the eye. In these experiments mean facility of
outflow values at the start of the experiment ranged between
-1 -10.24 and 0.28|il min mm Hg and rose to values between 0.36 and 
O.SOpl min ^ mm ^Hg after two and a half hours. A washout 
effect of similar magnitude occurred in the dead rabbit eye 
perfused in situ, where facility of outflow increased from 0.20 
to 0.4jil min ^ mm ^Hg following a five hour perfusion (Ruben et 
al, 1985).
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Early experiments by Barany and co-workers (1954; 1955)
implicated the importance of hyaluronic acid, a 
glycosaminoglycan, as an element of resistance in the outflow 
pathway. Removal of this substance by perfusion could be 
responsible for the washout effect. In these experiments the 
perfusion of testicular hyaluronidase (TH) into enucleated 
cattle and rabbit eyes decreased outflow resistance by 50%. 
Therefore, although these results imply that HA offers some 
resistance to outflow, some other barrier which is insensitive 
to TH also exists. The existence of another barrier was also 
not excluded in experiments by Knepper et (1984). In these
experiments the glycosaminoglycan profile of the trabecular 
meshwork was examined before and after chamber perfusion of the 
rabbit eye in vitro. Although facililty of outflow increased by 
40% in sixty minutes, when compared to the non-perfused control 
eyes, no effect on the glycosaminogylcan profile was seen.
Although in the present experiments the "washout" effect 
appears to be time-related it can be demonstrated in a 
comparatively short period of time. In 1967, Pandolfi 
determined outflow resistance by measuring the time taken for a 
known volume of fluid to flow from the reservoir into the 
chamber under an applied pressure of 20mmHg. When the volume of 
fluid perfused over several minutes was varied from 50 to 500^1 
the apparent facility of outflow subsequently increased from 
0.24 to 0.36jjl min”  ^ mm”^Hg. This result implies that it is the 
total volume of fluid passing through the meshwork, which 
determines the extent of the washout effect.
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It has been suggested that perfusate washout of some 
endogenous fibrinolytic inhibitor is responsible, at least in 
part, for the washout effect. E - aminocaproic acid (EACA), an 
established inhibitor of plasminogen activation and/or plasmin 
activity, exerted a powerful stabilizing effect during prolonged 
perfusion experiments (Ruben et ad, 1985). However perfusion of 
the enucleated rabbit eye with plasmin did not alter outflow 
resistence (Pandolfi, 1967). In addition little plasminogen 
activator activity, plasminogen or inhibitors of plasminogen 
activator activity have been demonstrated in the region of the 
collector channels or in the normal aqueous humour of the rabbit 
eye (Pandolfi et 1964, Saiduzzafar, 1970).
In conclusion although perfusate washout of HA or 
fibrinolytic inhibitors may be responsible for the "washout" 
effect, the precise mechanism(s) remains to be elucidated.
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2 ) Pseudofacility
In the rabbit eye a majority of AH is formed by a
pressure-independent secretory process, although a smaller 
proportion is formed by ultrafiltration, the pressure sensitive 
part of AH formation. As a result of a pressure difference
between the capillaries which supply the ciliary processes and
the ciliary stroma (Bill, 1975. Fig 2. ) an ultrafiltrate is
formed in the ciliary storma. Although the leaky junctions 
present at the apices of the pigmented and non-pigmented 
ciliary epithelium usually oppose the movement of materials from 
the stroma to the posterior chamber, they do allow the 
possibility of a pressure-dependent flow of salts and water (but 
not proteins) from the stroma to the posterior chamber. Since 
the pressure difference between the ciliary stroma and the 
posterior chamber is very small, the amount of filtrate entering 
the posterior chamber is comparatively small. Nevertheless, if 
the following assumptions are made.
a) that the driving force for the formation of the 
ultrafiltrate is the difference between hydrostatic 
pressures in the ciliary stroma and the posterior chamber,
b) capillary permeability and pressure remain constant during 
the experiment,
c) the integrity of the ciliary epithelium (the blood-aqueous 
barrier) remains constant,
then any change in lOP may alter the amount of ultrafiltration. 
Certain changes in blood pressure could also influence 
ultrafiltration.
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Determinations of facility of outflow by perfusion under 
constant pressure measure gross facility of outflow, ie
^True  ^ ^Pseudo’
Pseudofacility is the suppressibility of the pressure-dependent 
portion of AH formation. In the present experiments facility of 
outflow is measured when IOP is artificially raised by 4mmHg. 
This rise in pressure can alter the pressure gradient across the 
ciliary epithelium such that the driving force for 
ultrafiltration can decrease. In fact, there would be a
tendency for fluid to flow back across the ciliary epithelium 
into the ciliary stroma. Therefore, during facility
determinations fluid entering the eye replaces AH forced to
leave the eye by the applied pressure and by decreased or 
reversed ultrafiltration ie true and pseudofacility, 
respectively.
During the course of the present experiments, IOP gradually 
decreased, tending to increase the pressure gradient across the 
ciliary epithelium which in turn would increase the amount of AH 
formed by ultrafiltration. Although a certain amount of 
pseudofacility probably exists throughout the experiment, it
need not necessarily rise as lOP falls since the applied 
pressure during facility determination is constant throughout 
the experiment. In the perfused eye of the urethane
anaesthetised rabbit pseudofacility was estimated at 0.056ul 
min”  ^ mm~^hg (Green and Padget, 1979). Unfortunately the 
contribution of pseudofacility to the gross facility
measurements in these experiments is unknown.
The effects of various drugs on pseudofacility will be
discussed in the appropriate sections.
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3 ) Trauma
In an attempt to minimize the extent of trauma induced by 
the experimental procedures necessary to measure facility of 
outflow, pilot experiments investigated the optimal conditions 
under which these experiments were to be conducted. These 
procedures are detailed in the Materials and Methods Section. 
Nevertheless since the rabbit eye is a particularly sensitive 
stucture, needle insertion, perfusion of an artificial solution, 
and/or the prolonged presence of a needle within the anterior 
chamber, may be enough to induce trauma. Possible mediators of 
ocular trauma responses include PGs. (for a more detailed 
discussion of the ocular responses to PGs see Introduction). 
When applied to the eye larger doses of PGs produce responses 
similar to those induced by trauma, ie an increase in lOP, a 
breakdown of the blood-aqueous barrier, aqueous flare and pupil 
constriction. Closely correlated with such trauma responses is 
the appearance of PGs in the AH. If PGs are released in the 
present experiment in large enough concentrations then perhaps 
some of the ocular responses to PGs may have developed during 
the present experiments. In control eyes there was neither 
visible aqueous flare, pupil constriction, nor a rise in lOP. 
As an indication of the integrity of the blood aqueous barrier, 
which perhaps reflects the degree of trauma manifested in the 
eye during the experiment, AH protein concentrations were 
measured. When compared to non perfused - non drug treated 
eyes, perfusion of control or vehicle treated eyes did not 
significantly alter AH protein concentrations. This suggests 
that only very small concentrations of PGs, if in fact any, are 
released in these experiments. In support of this contention 
was the failure of indomethacin and piroxicam pretreatment to 
suppress the gradual rise in facility of outflow observed in 
control perfusion
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experiments in the anaesthetised rabbit.
Several PGs have been reported to increase gross facility 
of outflow, an effect attributed to pseudofacility. Although it 
appears that the concentrations of PGs released in the present 
experiments did not alter the integrity of the blood aqueous 
barrier such that proteins entered the AH, enough may have been 
released to alter pseudofacility. Doses of exogenous PGs as 
small as 10 to 250ng have been shown to increase AH formation 
and pseudofacility (See Introduction - The Ocular Responses To 
Prostaglandins). Although the time-course of these responses 
are not identical to those of present experiments, nevertheless 
the data do show that PGs have the ability to increase AH 
formation and pseudofacility. PGs may increase AH formation by 
increasing ultrafiltration or active secretion across the 
ciliary epithelium. PGE^ increases the passive permeability of 
the isolated rabbit ciliary processes (Green and Padgett, 1977).
PGE, increased the pressure index of the capillaries supplying 
the ciliary processes. This in turn could increase the amount 
of ultrafiltrate entering the ciliary stroma from the 
capillaries. This alone may not increase the amount of 
ultrafiltrate entering the posterior chamber, but coupled with 
the increased passive permeability of the ciliary epithelium it 
would tend to increase the amount of AH formed by ultra­
filtration. Therefore in the present experiments trauma-induced 
production of PGs may increase pseudofacility, which in turn 
would be a part of the gross facility measured in the present 
experiments. However neither indomethacin or piroxican pre­
treatment prevented this time-related rise in facility of 
outflow. Experiments where gross facility of outflow showed 
signs of rising spontaneously by greater than 20% in thirty 
minutes were discontinued in an attempt to minimize the contri­
bution of trauma in an experiment.
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The Effect of Adrenaline On Facility of Outflow In The
Anaesthetised Rabbit
In the present experiments topically applied adrenaline
(O.Smg) raised facility of outflow. This outflow response was
observed half an hour following the application of adrenaline
and was sustained for the remainder of the experiment. Such an
early outflow response to adrenaline in the rabbit eye has not
been reported elsewhere. Similar results were obtained in
earlier perfusion studies by Lamble (1974;1977). However in
these experiments adrenaline (O.Smg) was applied to the eye
prior to the experimental procedures necessary to measure
facility of outflow. This meant that the earliest possible
measurement of outflow was 50 minutes following the application
of adrenaline. Although adrenaline raised the facility of
outflow, this rise, relative to the vehicle treated eye, was
only half as great as observed in the present work. Whereas in
these experiments responses to adrenaline did not significantly
increase beyond 50 minutes, in the present work the adrenaline-
induced rise in facility continued at least until 90 minutes
after administration. In view of the similar starting values
for facility of outflow and methods used to measure outflow
facility, other than biological variation, there is no apparent
reason for such marked differences in the outflow response to
adrenaline. However an outflow response of similar magnitude
and duration has been reported in the monkey eye (Kaufman and
Barany, 1981). Approximately 15 to 35 minutes following the
intracameral injection of adrenaline (lOug) or NA (lOjig)
-1
facility of outflow had increased by 0.185 and 0.201|il min 
-1
mm Hg respectively.
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similarly, 45 minutes following the topical administration of a
2% solution of adrenaline, facility of outflow was raised by 
-1 -1
0.35jLil min mm Hg (Bill,1969).
Although it has been assumed that the rise in facility of 
outflow following adrenaline treatment was due to adrenaline, 
other factors may contribute to this rise.
During a perfusion experiment there is a gradual rise in 
facility of outflow in both control or vehicle-treated eyes. 
Since this gradual rise will also exist in the adrenaline -
treated eyes, it is therefore particularly important to note 
that the rise in outflow facility seen in the adrenaline -
treated eye was always significantly higher than the rise seen 
in the contralateral vehicle-treated eye, implying that 
adrenaline had further increased facility of outflow. Kaufman 
and Barany (1981) have also shown that the percentage increase 
in facility of outflow caused by adrenaline or NA was
significantly greater than that caused by perfusion alone.
Although pseudofacility exists in the present experiments 
we believe that in the control situation it is constant
throughout the experiment. However, it is possible that a drug 
may alter pseudofacility. An adrenaline induced rise in 
pseudofacility has been reported in both the rabbit and monkey 
eye (Barany, 1968; Bill, 1969; Green and Padgett, 1979).
In experiments where the hydraulic conductivity of the 
isolated ciliary body-iris preparation was measured, adrenaline 
(10 ® to ^M) increased the passive water permeability of the 
ciliary epithelium by 15 to 86 percent (Green and Griffen, 1978) 
This increase in passive permeability would suggest that 
pseudofacility should be increased.
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Following the infusion (^H) inulin into the anterior
chamber of the urethane-anaesthetised rabbit, Green and Padgett
(1979) investigated the pressure-dependency of AH formation and
the effect of adrenaline on pseudofacility. Pseudofacility was
calculated from values obtained for facility of outflow during a
period of artificially elevated lOP according to the method of
Maori (1967). The collection of fluid effluent from the eye
approximately four hours following the topical application of a
comparitively high dose of adrenaline (2mg), showed that
-1 -1adrenaline had raised pseudofacility from 0.056jjl min mm Hg
-1in the control eye to 0.086jil min mm Hg. Comparison of this 
data with results obtained in the present experiments 
illustrates two points. Firstly, in the control experiments 
pseudofacility can account for as much as 22% of the gross
facility of outflow. Secondly and perhaps more importantly, the 
adrenaline-induced rise in pseudofacility can account for only a 
small proportion of the rapid rise in facility of outflow 
following adrenaline treatment.
In an attempt to establish the effect of adrenaline on true 
and pseudofacility, facility of outflow in the vervet monkey eye 
was studied using both a conventional and a new anterior chamber 
perfusion technique (Barany, 1968). In the conventional two 
level constant pressure perfusion technique, gross facility of 
outflow was measured by periodically raising and lowering lOP 
while extraocular venous pressure remained unaltered. With the 
newer technique the pressure head required to force AH through 
the outflow channels was obtained by lowering and raising venous 
pressure while lOP was unaltered. Venous pressure was altered 
by changing the positive pressure against which the animal was 
breathing. Since lOP was unaltered during
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this technique AH formed by ultrafiltration was minimally 
affected. Therefore in these experiments facility measured 
approached true facility. Pseudofacility was estimated as the 
difference between the results of these two techniques in the 
same eye. Approximately one hour following the topical 
application of two drops of a two percent solution of 
adrenaline, pseudofacility had increased from 0.092 in control 
eyes to 0.144|ilmin~^ mm”^Hg in the adrenaline-treated eyes. In 
1969 Bill calculated that one drop of a two percent solution of 
adrenaline raised pseudofacility from 0. 025 to 0.036jilmin  ^
mm Hg. Although these values are lower than those reported by 
Barany (1968), they may be explained by the higher arterial 
blood pressure measured in these experiments which would tend to 
decrease pseudofacility (Bill, 1970).
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The Effect of Adrenaline on lOP In The Anaesthetised Rabbit.
As expected, topically applied adrenaline significantly 
lowered lOP. Unexpected was the significant fall in pressure in 
the contralateral vehicle-treated eye which meant that there was 
no significant difference between lOP in the adrenaline and 
vehicle-treated eyes. This phenomenon cannot be explained by a 
consensual action of adrenaline since the same concentration of 
adrenaline which lowered lOP in the drug-treated eye, failed to 
lower I OP in the contralateral vehicle-treated eye of the 
conscious rabbit. However, it has previously been reported 
(Lamble, 1974,1977) that the effect of adrenaline on ocular 
tension was apparently reduced or reversed by the procedures of 
anaesthesia and cannulation performed to enable facility 
determinations. Thus when lOP was measured manometrically there 
was often no significant difference between values observed in 
adrenaline and control eyes, whereas when lOP was measured using 
tonometry lOP was significantly lower in the adrenaline-treated 
eye. In both these and present experiments it was frequently 
observed that the administration of urethane subsequent to 
initial doses of anaesthetic and cannulation of the anterior 
chamber were often accompanied by a irreversible lowering of 
lOP. This and the gradual fall in IOP seen during the 
experiments could be the result of a urethane-induced reduction 
in aqueous humour formation which has been reported in the 
rabbit eye (Barany, 1950). One must therefore conclude that the 
fall in lOP normally induced by adrenaline may often be obscured 
in the urethane anaesthetised rabbit.
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The PD Responses To Adrenaline In The Conscious And
Anaesthetised Rabbit
Adrenaline (0.25 and 0.5mg) applied topically to the rabbit 
eye produced mydriasis. The duration of the PD response in 
these experiments agrees with previously reported data, ie a 
rapid mydriasis which is maximal within half to one hour 
(Langham and Krieglstein, 1973; Langham et al, 1976; Lamble,
1977 ). However the magnitude of this response (2mm in the
conscious and approximately 3.6mm in the aneasthetised rabbit) 
was smaller than the peak increase of approximately 5mm reported 
elsewhere (Langham and Krieglstein, 1973). This is probably due 
to the substantially higher starting PD values encountered in 
the present work.
Intravenous pretreatment with either phenoxybenzamine or 
phentolamine ( 5mg kg in each case) completely blocked the PD 
response to 0.5 and 1.5mg of adrenaline (Langham et 1973;
Langham and Krieglstein, 1976). These results suggest that 
adrenaline induced mydriasis is predominantly an alpha
adrenoceptor mediated response. Therefore it is not surprising 
that in the present experiments in the anaesthetised rabbit 
topical timolol failed to reverse the pupillary responses to 
adrenaline (0.5mg). However, topical pretreatment with
thymoxamine (2.5mg) inhibited the mydriatic responses to
topically applied adrenaline (0.5mg) by approximately 75% 
(Lamble, 1977). These findings suggest that although alpha 
induced contraction of the dilator pupillae is primarily 
responsible for the adrenaline induced mydriasis, there may be 
another smaller component consisting of beta receptor mediated 
relaxation of the iris sphincter.
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The Effect Of Timolol Treatment On The Ocular Responses To
Adrenaline In The Anaesthetised Rabbit.
Timolol was used as a pharmacological tool in the present
experiments to investigate the involvement of the beta
adrenoceptor in the outflow response to adrenaline. However, 
the mechanism of action of timolol is complicated since in 
addition to being a beta receptor antagonist, timolol is also a 
potent hypotensive agent in the normo- and hypertensive human 
eye (Katz et 1977; Zimmerman and Kaufman, 1977). Although
timolol did not alter the progressive rise in outflow facility 
seen during the course of control experiment it did largely 
reverse the outflow response to adrenaline, confirming that this 
was infact a true drug response mediated via a beta
adrenoceptor. Although the exact location of this receptor is 
unknown the concentration of timolol present in the eye is 
believed to be in excess of that required to block beta 
receptors. Following its topical administration timolol rapidly 
appears in the aqueous humour; for example, the topical 
application of 25^g results in 5. 7jiM timolol in the AH 30 
minutes later. (Varieties ^  1977;). Nathanson ^  al,(1980)
have shown that as little as 2.5uM timolol was needed to block 
the stimulation of ciliary process adenylate cyclase by 
isoprenaline. If it is true that adrenaline lowers lOP by 
raising outflow facility then the failure of timolol to reverse 
the pressure response, while reversing the outflow response to 
adrenaline is perhaps unexpected.
In an extensive study by Vareilles et (1977) the
hypotensive action of timolol (1 to lOOjig) in the normo 
tensive rabbit eye was shown to be inconsistent. In contrast 
Innemee and van
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Zwieten (1982) have shown that timolol applied to the normal 
rabbit eye significantly reduced lOP 1 to 2 hours later. 
In direct conflict, Boas et ad., (1981), have shown that a dose 
of timolol identical to that used in the present experiments, 
failed to lower lOP in the normotensive rabbit eye and also 
failed to block adrenaline (100|ig) induced ocular hypotension.
The pressure responses to timolol in the hypertensive 
rabbit eye are more consistant than those in the normotensive 
rabbit eye. Timolol (1 to lOOug) reduced lOP elevated by either 
an oral water load or by pretreating intracamerally with alpha 
chymotrypsin (Vareilles e;t a]., 1977 and Schmitt, et 19&) ) .
In these experiments concentrations of timolol as low as O.lyg 
blocked the hypotensive activity of isoprenaline (lOug) in the 
water-load model of ocular hypertension.
In the present experiments timolol reversed the adrenaline 
induced rise in outflow. Ihe apparent failure of timolol to 
significantly alter the hypotensive response to adrenaline could 
be explained by the direct effect of timolol in lowering lOP in 
the rabbit eye (Innemee and van Zwieten, 1982), or by the slow 
reduction in lOP observed during any long experiments in the 
anaesthetised rabbit. Alternatively since the volume changes 
involved are small perhaps one would expect reversal of the 
pressure response to adrenaline to occur beyond the time 
restraints of the present experiments. It has also been 
proposed that the reduction of lOP by catecholamines in the 
presence of timolol was due to alpha adrenoceptor stimulation 
which is not blocked by the beta-adrenoceptor antagonist.
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The Effect of Indomethacin Pretreatment on the lOP
Responses to Adrenaline in the Conscious Rabbit.
In 1977, Bhattacherjee and Hammond showed that topical 
pretreatment with indomethacin (0.125mg) abolished the
hypotensive response to chronic adrenaline (Img) treatment. 
Although the present results confirmed these early findings, more 
importantly, they showed that acute indomethacin pretreatment 
could infact antagonise the acute hypotensive response to 
adrenaline. A similar finding has recently been reported in the 
human eye (Camras et aT, 1985). In a randomized double-masked 
study, a 2% solution of adrenaline applied topically, twice daily 
for 2 weeks, to the eyes of patients with glaucoma or ocular 
hypertension caused a 29% reduction in lOP of placebo-treated 
patients, but only a 9% reduction in I OP in patients treated
orally with indomethacin (25mg, 4 times daily ).
Results obtained in both rabbit and human eye, therefore, 
suggest that at some stage following the interaction of 
adrenaline with its receptor, PCs are produced which may be
responsible, at least in part, for adrenaline-induced 
hypertension.
In the present experiments adrenaline also produced initial 
ocular hypertension, a response which appeared to be partially 
blocked by indomethacin pretreatment. This is perhaps unexpected 
in view of previously published results. Potter et al,
(1982,1983) have shown that pretreatment with a competitive 
inhibitor of PG endoperoxide synthetase, flurbiprofen, for 3 
days, did not inhibit the development of isoprenaline-induced
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ocular hypotension. Similarly Unger, (1979) has shown that when 
topical adrenaline (50mg) is given for 4 days and on the fifth 
day is preceeded by topical indomethacin pretreatment (25mg 
topically and lOmg kg  ^ intraperitoneally) subsequent
adrenaline treatment continued to initially raise lOP. However, 
Langham and Palewicz(1977) have proposed that this initial 
hypertensive response which is independent of PG biosynthesis, is 
the result of the interaction with alpha-adrenoceptors on intra- 
and episcleral blood vessels as well as aqueous veins causing 
vasoconstriction which offers resistance to the flow of AH and 
subsequently causes ocular hypertension. Alternatively, if 
adrenaline-induced hypertension in the rabbit eye is the result 
of extraocular muscle contraction (Rowland and Potter,1980), then 
it is conceivable that indomethacin could block such contraction 
by virtue of its inhibition of calcium movements (Northover, 
1977,1980,1982).
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The Effect Of Indomethacin Pretreatment On The Pressure And
Outflow Responses To Adrenaline In The Anaesthetised Rabbit.
Since adrenaline appeared to lower lOP by raising facility 
of outflow the effect of indomethacin pretreatment on this more 
fundamental response to adrenaline was particularly interesting.
In the present experiments there was a tendency for 
facility of outflow to increase during the course of an 
experiment, a trauma response to adrenaline probably induced by 
the procedures required to measure outflow facility and which may 
involve PGs. It was therefore important that indomethacin 
pretreatment failed to alter this response. Nonetheless,
indomethacin pretreatment inhibited the adrenaline-induced rise 
in outflow facility and subsequent fall in lOP. Although these 
results strengthen the idea that PGs are involved at some stage 
in the adrenaline-induced rise in facility of outflow and fall in 
lOP, one must also consider the other properties of indomethacin.
Indomethacin possesses several actions which are 
antagonistic to those of calcium in several biological
situations. The calcium content of smooth muscle following 
electrical stimulation is reduced by indomethacin (Northover, 
1971,1972: Burche et 1983). By reducing the availability of
of calcium within the cell, indomethacin disrupts
excitation-contraction coupling and therefore it is not 
surprising that indomethacin can inhibit the contraction of most 
types of vascular smooth muscle (Northover,1967). Similarly, the 
release of lysosomal enzymes from polymorphonuclear lymphocytes, 
a process which also requires calcium, is inhibited by 
indomethacin (Ignarro and George, 1974; Rossi et ^  , 1976).
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By investigating the effect of other PG synthesis inhibitors 
and calcium antagonists on the ocular responses to adrenaline in 
both the conscious and anaesthetised rabbit it was possible to 
determine that indomethacin was not acting as a calcium 
antagonist.
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The Effect Of Verapamil Pretreatment On The Pressure Responses
To Adrenaline In The Conscious Rabbit.
Verapamil is a calcium channel blocker which prevents the 
influx of extracellular calcium into cells. If indomethacin were 
acting mainly as a calcium antagonist in the present study then 
verapamil might have been expected to have similar effects on the 
pressure responses to the adrenaline.
Present results show that verapamil produces a 
dose-dependent lowering of lOP, with consensual effects at higher 
concentrations.
In direct conflict, Beatty et al,(1984), have shown the 
topical administration of similar doses of three different 
calcium channel blockers (verapamil, diltiazem or nifedipine) 
produced a transient rise in lOP. Although facility of outflow 
and episcleral venous pressure were unchanged, AH inflow appeared 
to have increased when estimated by the Goldman equation or by 
changes in anterior chamber fluorescein-labelled dextran 
concentration. However, AH ascorbate and turnover of radioactive 
iodide did not differ from that in the untreated eye. It is 
believed that the ocular hypertensive effect of verapamil is 
related to ocular vasodilation. Since adrenaline (1%) and 
phenylephrine(10%) prevented the elevation of lOP by verapamil, 
it is possible that the vasconstricive properties of these agents 
may be preventing the verapamil-induced vasodilation.
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The cellular mechanism involved in the ocular hypo-and 
hypertensive responses to verapamil are unclear. Intraperitoneal 
indomethacin pretreatment (10 to 50mg kg -1) left the 
hypertensive response to verapamil unaltered (Beatty et al,1984). 
AH protein concentrations were also unaltered. Thus the effect 
of calcium channel blockers on lOP does not seem to be PG 
mediated.
If the hypertensive response to adrenaline is the result 
of extraocular muscle contraction then the partial anatagonism of 
this response by the verapamil in the present experiments is not 
surprising. Of greater importance was the failure of verapamil 
to alter the hypotensive response to adrenaline which suggests 
that in previous experiments the ability of indomethacin to 
antagonise the outflow and pressure response to adrenaline was 
probably not related to calcium antagonism.
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Th# Effect Of Systemic Aspirin Pretreatment On The Pressure and
Outflow Responses To Adrenaline In The Anaesthetised Rabbit,
-1
Systemic pretreatment with aspirin (200 mg kg rectally) 
had no effect on baseline outflow or lOP measurements in the 
anaesthetised rabbit. Similarly in the conscious rabbit iv 
injection of aspirin (2.5 to 17.5 mg kg ^ ) had no influence on 
lOP (Wizemann ^  ^  ,1982).
In view of the present observation that indomethacin blocks 
both the outflow and pressure responses to adrenaline, perhaps it 
is surprising that aspirin pretreatment altered neither of these 
responses nor their inhibition by indomethacin. It is possible 
that this concentration of aspirin is well below that required to 
inhibit PG biosynthesis or the reason is aspirin's far lower 
potency as an inhibitor of cyclooxygenase.
Although Miller et ^  ,(1973) have shown that PG
biosynthesis by microsomal fractions of the anterior uvea are 
suppressed an hour after aspirin pretreatment (200mg 
kg-1,rectally), compared with the present experiments plasma 
salicylate levels were considerably higher, ie 18 and 30 mg 
percent respectively.
In 1974, Bhattacherjee and Eakins. investigated the
inhibitory activity of several non-stereoidal anti-inflammatory
drugs on ocular PG - like activity by microsomal fractions of the
anterior uvea and ID-50 values calculated. Indomethacin had an
ID-50 of 18.5jj| ml ^ whereas with aspirin no inhibition could be
-1
detected even with concentrations as high as 200 to 300 jig ml
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Depending upon their response to adrenaline, the animals in 
this series of experiments appeared to fall into two categories, 
those which showed an outflow and pressure response to adrenaline 
and those which did not. The former have already been discussed.
Since adrenaline produced mydriasis in both populations of 
animals it seems that drug penetration cannot explain the lack of 
an outflow and/or pressure response to adrenaline. It is 
possible that the absence of these responses are a result of high 
plasma salicylate levels . Unfortunately plasma salicylate 
levels were measured in only 2 of these rabbits and in both 
instances the levels were similar to those of the rabbits whose 
lOP did respond to adrenaline. Although it appears that for no 
apparent reason some rabbits fail to show a pressure response to 
adrenaline this is a phenomenon commonly observed in both the 
conscious and anaesthetisted rabbit (personal communications, 
D.Gilbert, S.Bartels).
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The Effect Of Piroxicam Pretreatment On % e  Ocular Responses To
Adrenaline In The Conscious And Anaesthetised Rabbit
In 1983 Burche et ^  , assessed simultaneosly the effects of
45 2+indomethacin and piroxicam on both the uptake of Ca into 
hamster liver mitochondria and microsomes and PG synthesis in 
these organelles. Indomethacin inhibited calcium movements into 
these subcellular fractions at concentrations only twenty times 
those required to block PG synthesis (ID^g of 90 and 5jiM, 
respectively). In contrast piroxicam did not alter calcium 
movements at concentrations up to 300 ^ M . , while the ID^q for the 
inhibition of PG synthesis was 0.35 jiM. The mechanism for 
inhibition of ^^Ca^^ transport by indomethacin is unclear but 
does not appear to be related to cyclo-oxygenase inhibition since 
it was not reversed by the addition of exogenous PGs. The use of 
piroxicam in the present study distinguished between direct 
effects on calcium movements versus actions mediated through 
cyclo-oxygenase inhibition.
In the conscious rabbit low concentrations of piroxicam had 
no effect on lOP while higher concentrations lowered lOP 
suggesting that endogenous PGs may be involved in maintaining 
lOP. Using direct or tracer dilution techniques to measure AH 
formation, PGs have been reported to raise AH formation in the 
rabbit eye (Masuda and Mishima, 1973; Green and Padgett, 1979). 
If endogenous PGs have similar effects on AH formation, and are 
involved in the maintenance of IOP then inhibition of PG 
production could result in a lowering of lOP. However, in the
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- 1
anaesthetised monkey indomethacin (3mg kg injected iv) had no 
clear effect on AH formation (Sperber and Bill 1984). 
Nonetheless in - vivo and in - vitro studies have shown that 
indomethacin enhances spontaneous fluid absorbtion in the rabbit 
small intestine and reduces the amount of fluid that accumulates 
in response to several secretory stimuli (Wald ^  aJ^ , 1977; Smith 
^  1981) .
Following piroxicam pretreatment in the conscious rabbit, 
both the hyper - and hypotensive response to adrenaline were 
unaltered. The failure of piroxicam to block either of these 
responses could not be attributed to the hypotensive action of 
piroxicam since at this concentration it had no effect on lOP. 
Although piroxicam is a relatively more potent inhibitor of PG 
biosynthesis than indomethacin in the liver, this does not 
necessarily mean that a similar situation exists in the eye. The 
pharmacological profile of activity of a viriety of non-steroical 
anti-inflammatory compounds including indomethacin and asprin, 
was found to differ in ocular tissues from that in other tissues 
such as the spleen and seminal vesicles (Bhattacherjee and 
Eakins, 1974). It is also possible that piroxicam cannot 
penetrate the cornea as easily as indomethacin.
Subsequent experiments in the anaesthetised rabbit using a 
higher dose of piroxicam, yielded particulary important results. 
While indomethacin, a known calcium antagonist, partially 
inhibited the hypertensive response to adrenaline, piroxicam, a 
compound relatively devoid of calcium antagonistic properties had 
no effect on this transient rise in pressure. These results 
therefore suggest that calcium may be involved, possibly through 
inhibition of extraocular muscle contraction, in the hypersensive 
response to adrenaline. However of greater interest was the
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ability of both indomethacin and piroxicam to largely inhibit the 
adrenaline - induced rise in facility of outflow and subsequent 
fall in lOP, strongly suggesting that PGs are involved at some 
stage in these responses to adrenaline.
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The Involvement of The Beta Adrenoceptor and PGs In The Oatflow
and Pressure Responses To Adrenaline.
The reversal of the adrenaline induced rise in facility of 
outflow by timolol is in keeping with the theory that a 
beta-adrenergic mechanism is involved in the hypotensive response 
to adrenaline (See Introduction:- The Biochemical Mechanism of 
Action of Adrenaline In Lowering lOP). However the ability of 
indomethacin and piroxicam to antagonise the outflow and pressure 
response to adrenaline suggests that following the interaction 
with the beta adrenoceptor PGs are produced which may also be 
responsible for the afore mentioned responses to adrenaline. The 
more widely accepted view is that beta adrenoceptor stimulation 
results in the production of cAMP and many workers (Neufeld et 
al, 1972; Neufeld and Sears, 1974 and Neufeld et 1975)
believe that it is this cAMP which is responsible for the ocular 
responses to adrenaline. In the light of the ability of 
indomethacin to antagonise the cAMP-induced rise in facility of 
outflow one may be tempted to postulate that cAMP triggers PG 
synthesis. Although there is little evidence in the literature to 
support such a hypothesis the present attempt to raise facility 
with cAMP and block the rise with piroxicam might have lent 
weight to this idea had the technical problems been overcome.
The formation and release of PGs in response to adrenergic 
stimuli has been demonstrated in the eye. Bhattacher jee et al, 
(1979) demonstrated an adrenaline-induced rise in PG synthesis by 
rabbit ocular tissues.
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similarly, Engstrom and Dunham (1982) examined the effect of
phenylephrine on the synthesis and release of PGs from isolated
rabbit iris-ciliary body (ICB) slices. Phenylephrine (lOjiM)
enhanced the synthesis of PGs E^ and from superfused ICB
-1
slices, a response abolished by indomethacin (5g ml ). 
Therefore, from these and present results one could well imagine 
adrenaline stimulating PG production. However the ability of 
phenoxybenzamine to antagonise the phenylephrine-induced rise in 
PG generation by ICB slices (Engstrom and Dunham, 1982) suggests 
that adrenergic induced production of PGs may occur through an 
alpha adrenoceptor. In general, relatively selective alpha 
adrenoceptor agonists, including phenylephrine and St-587, are 
minimally effective in lowering lOP in both rabbits and humans 
(Potter and Rowland, 1978; Innemee et aT, 1982; Lee and Brubaker, 
1982/83) and do not seem to have a profound effect, if any, on AH 
formation or outflow (Green and Griffen, 1978; Green and Padgett, 
1979 and Lee and Brubaker, 1982/83). Since adrenaline raises 
facility of outflow and subsequently lowers lOP, and timolol 
reverses these responses, it is difficult to envisage an alpha 
adrenoceptor being involved in these responses to adrenaline.
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The Effect Of Drug Treatment On AH Protein Concentrations.
Since the rabbit eye is a particularly sensitive structure 
it is possible that the present experimental procedures may 
traumatise the eye. Trauma responses could include miosis, 
hyperaemia, a rise in lOP and/or a breakdown of the blood aqueous 
barrier. Therefore in the present experiments AH protein 
concentrations, measured at the end of each perfusion experiment 
were used as one indication of the health of the eye. Pupil 
size, lOP and flare were also watched.
Although Miller et ad^  (1973) reported that the protein
-1
content of primary AH was 1.2mg ml , levels found in the present 
experiments were comparatively smaller, ie 0.5mg ml . Since AH 
protein levels were unaltered following perfusion of the eye it 
appears that only minimal if any, breakdown of the blood aqueous 
barrier occurred during the present experiments.
Topically applied adrenaline raised AH protein
-1
concentrations. Similar concentrations (approximately 2mg ml ) 
were found in the AH following topical treatment with either 0.1% 
NA or 10% phenylephrine (Unger, 1979).
In 1971, Takase reported a NA-induced fall and an iso 
prenaline-induced rise in AH protein concentrations. While 
pretreatment with propranolol suppressed the isoprenaline induced 
rise, phentolamine inhibited both this rise and the NA induced 
fall in protein concentrations. Consequently it was thought that 
alpha adrenoceptor stimulation reduced and beta stimulation 
increased the permeability of the blood aqueous barrier. Since 
adrenaline can stimulate both alpha and beta receptors it is 
possible that a similar situation exists in the present work and
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that a moderate increase in protein is the net effect of 
adrenaline.
Although indomethacin can antagonise the paracentesis- 
induced rise in AH protein concetration, (van Haeringen et al, 
1982), neither indomethacin nor piroxicam altered the 
adrenaline-induced rise in AH protein concentrations. This 
suggests that this was a true drug effect and not a trauma 
response.
Again in the present experiments, the injection of saline 
into the AC raised facility of outflow, an apparent trauma 
response. Nonetheless AH protein concentrations were unaltered. 
It therefore appears that certain trauma responses can occur 
without any significant breakdown of the blood aqueous barrier.
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Measurement of AH PG Concentrations Using RIA
Measuring PG concentrations in the AH was a more direct way 
of investigating the possible involvement of PGs in the ocular 
responses to adrenaline. Therefore in the present experiments 
AH was obtained by paracentesis from the eyes of conscious 
rabbits following adrenaline treatment and PG levels measured 
using RIA.
Initial experiments showed that the assay was not sensitive 
enough to detect the apparently low concentrations of PGs 
present in both vehicle-and adrealine-treated eyes. In an 
attempt to concentrate the levels of PGs to be measured, pooled 
AH samples were extracted, dried, reconstituted and then 
assayed. However, when samples treated in this fashion were 
assayed, the antibody appeared to bind more labelled PG than the 
"total bound" sample which contained neither extract or 
exogenous PG. This implied that these procedures in some way 
altered the binding properties of the antibody. Alternatively, 
some component of the AH may be responsible. Although the 
effect of extraction alone could not be directly determined it 
did not appear to be involved since changing the solvent system 
did not eliminate the afore mentioned phenomenon.
In view of the low concentrations of PGs detectable it was 
clearly necessary to attempt to concentrate the samples. Hence 
the use of internal standards of PG in the pooled AH samples, so 
that any loses of material or changes in binding due to any 
component of the AH would affect the standard PG to the same 
extent as the endogenous PG. Although following these
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procedures the samples containing AH no longer bound more
exogenous PG than the "total bound" sample, which was used to
construct a standard curve, the sensitivity of the assay was so
poor that it could not differentiate between relatively high and
low concentrations of standard PG. It therefore seemed that the
RIA used in the present experiments could be used neither to
accurately measure low concentrations of PG nor differences in
PG levels before and after drug treatment. Nontheless it might
be estimated that AH from rabbits treated with either adrenaline
or its vehicle contained less than lOpg of PGF2J^or PGE2.
PG levels in AH have been measured by other workers using
bioassay. When estimated by the inhibition of ADP-induced
platelet aggregation, basal levels of AH prostacyclin were
-1
estimated at 3ng.ml (Hoyng et aj^ , 1982), whereas AH assayed on
the isolated rat fundus strip had PG - like activity of
-1 1 O.Tng.ml which was reduced to 0.2ng.ml- following aspirin
pretreatment (Miller et ^1,1978). By comparison with the
present study, it appears that prostacyclin concentrations
exceed PGEg and P G F ^  concentrations. Since these values are
greater than the present study it appears that either these
bioassays are measuring more than just the compounds claimed or
else AH prostacyclin concentrations exceed PGEg and PGFg^
concentrations. Alternatively there is a serious unexplained
loss occurring in our extraction.
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The Effect Of Indomethacin and Piroxicam Pretreatment On The
Ocular Responses To Analogues of cAMP In The Anaesthetised
Rabbit.
It is widely accepted that stimulation of beta 
adrenoceptors by adrenaline raises intracellular levels of cAMP 
and this has been demonstrated in the AH. (See Introduction - 
The Biochemical Mechanism of Action of Adrenaline in Lowering 
lOP). Many workers believe that it is this cAMP which is 
responsible for the outflow and pressure responses to 
adrenaline. However, present results imply that PGs are 
produced which may also mediate these responses to adrenaline. 
In 1982, W.S.Wilson and Alisdair Campbell, reported that 
indomethacin pretreatment inhibited the outflow response to 
intracamerally injected dibutyryl cAMP, implying that cAMP 
stimulates PG production which in turn raises facility of 
outflow. Although similar results were obtained in the present 
study, the failure of piroxicam to antagonise the outflow 
response to either 8 bromo or dibutyryl cAMP suggested that this 
effect of indomethacin was not a result of inhibition of 
PGbiosynthesis. In the previous study (Wilson and Campbell, 
1982) control observations of the effect of intracamerally 
injected vehicle had not been carried out and were therefore 
investigated in the present study. Since both dibutyryl cAMP 
and its vehicle raised facility of outflow. It appeared that 
neither dibutyryl cAMP was having a consensual effect or that 
the injection procedure alone and not the drug was responsible 
for this rise. Although in subsequent experiments saline was 
injected into one
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eye only, facility of outflow was raised in both eyes. It 
therefore appeared that the dibutyryl cAMP -induced rise in 
outflow facility may have been an injection artifact.
In all of these experiments 2 needles had been inserted. 
Drugs were injected through one needle and the eye perfused 
through the other. However, since the eye is a particulary 
sensitive structure it is possible that the presence of these 2 
needles traumatised the eye which in turn caused a rise in 
facility of outflow. By inserting a "T" piece into the tubing 
attached to the perfusion needle, it is possible to both perfuse 
and inject into the‘ anterior chamber using only one needle. 
Nonetheless the injection of only small quantities of saline 
into the anterior chamber continued to raise facility outflow in 
both eyes. When compared to the NPND eye, perfusion of the 
anterior chamber alone did not raise AH protein concentrations. 
However, perfusion of the chamber in the presence of a second 
did raise protein levels (approximately 50% increase). If AH 
protein concentrations are indicative of the extent of trauma in 
the eye, then this result suggests that this was traumatic to 
the eye. Unfortunately these technical problems precluded any 
conclusions being drawn from these experiments. Therfore it has 
also been impossible to confirm a link between cAMP and the 
adrenaline induced rise in facility.
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APPENDIX
Appendix 1
Assay Solutions
(1) Radioimmunoassay buffer 
KH^PO^ 1.79g
NaCl 0.78g
Distilled water to 250ml
The pH of the solution was adjusted to 7.4 and then O.Sg of 
bovine gamma globulins were added.
(2) Dextran-coated charcoal solution 
Dextran-coated charcoal O.Sg
KH^PO^ Buffer to 100ml
(3) KH^PO^ Buffer (lOmM)
KH^PO^ 0.136g
Distilled water to 100ml
(4) Solution C for protein determination
Solution C 98 parts of solution A
2 parts of solution B
These are mixed on the day of use.
Solution A Sodium carbonate 2g
Sodium hydroxide (O.lN) add 100ml
Solution B Cupric Sulphate O.Sg
Sodium Potassium Tartrate l.Og 
Distilled Water add 100ml
(5) Ferric nitrate solution for salicylate assay
Ferric nitrate 40g
Mercuric chloride 40g
HCl (O.lN) to 1 litre
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APPENDIX (11)
Chemicals and drugs used
Chemical Manufacturer/Supplier
Adrenaline B.P. (Eppy)
L-ascorbic acid
Aspirin B.P. (Suppositories)
Bovine Gamma Globulins
Calcium Chloride
Dextran-Coated Charcoal
Ferric Nitrate
Folin Ciocalteu Reagent
D-Glucose
Halothane
Heparin Sodium(Mucous) (Pularin)
Hydrochloric acid
Indomethacin
Liquifilm Tears
Magnesium Chloride
Mercuric Chloride
Nitrogen (oxygen free)
Nitrous Oxide
Oxygen
Piroxicam
Potassium Hydrogen Phosphate 
PGEg Anti-sera 
6 Keto PGF^ Anti-sera 
Scintillant 
Sodium Carbonate 
Sodium Chloride
Smith and Nephew (Gift)
Sigma
Macarthys Ltd.
Sigma
Hopkin and Williams Ltd 
Sigma
May and Baker Ltd 
Sigma
Hopkin and Williams Ltd 
May and Baker Ltd 
Duncan Folckhart Ltd 
Hopkin and Williams Ltd 
Sigma 
Allergan
Hopkin and Williams Ltd 
Hopkin and Williams Ltd 
British Oxygen Company 
British Oxygen Company 
British Oxygen Company 
Pfitzer Ltd (Gift)
Hopkins and Williams Ltd 
Pharmacology Dept G.Ü. (Gift) 
Pharmacology Dept G.Ü. (Gift) 
Packard
Hopkin and Williams Ltd 
Koch Light Ltd
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Sodium Chloride (Minims) 
Sodium Hydroxide 
Timolol Maleate (Timoptol) 
Vehicle for Timolol 
Verapamil
Smith and Nephew (Gift) 
Hopkin and Williams Ltd 
Merk Sharp and Dohme (Gift) 
Merk Sharp and Dohme (Gift) 
Sigma
All chemicals were of Analar quality.
All radioactively labelled compounds were obtained from the 
Radiochemical Centre, Amersham.
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APPENDIX (111)
Statistics
(a) Statistical comparisons in the conscious rabbit.
Before lOP was measured using the tonometer the rabbits were 
accustomed to both the tonometer and laboratory conditions.
'vonetheless the animals were frightened by sudden movements or 
noises. As a result inter and intra rabbit measurements of IOP 
were variable. To minimize this variability 't ' tests were 
carried out on the mean differences between values at each time 
point within or between rabbits.
(b) Statistical comparisons in the anaesthetised rabbit.
Comparisons of responses within or between eyes were carried out 
using a 't ' test which compared the means of absolute values.
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Appendix IV
(a ) Precision
An example of the method for determining total facility of 
outflow (C) is given below.
Time
0 min 1 min 2 min 3 min 4 min 
Weight of reservoir 635mg 631mg 630mg 629.5mg 628.5mg
Fluid loss from reservoir 4.0mg l.Omg O.Smg l.Orag
Assuming a density of l.OOg ml  ^ 4jj1 of perfusion fluid 
left the reservoir during the first minute which probably 
represents compliance, (see Methods). C is calculated from the 
quantity of fluid leaving the reservoir over the next 3 minutes, 
ie. 2.5pl in 3 minutes. If during this period the record of IOP 
shows that the pressure applied by the reservoir was 3.8mmHg 
above ambient lOP, then
C =  ^  ^ = 0.2 2jjlmin ^. mm ^Hg 
3x3.8
Analysing the precision fo this method, the most reliable 
component of this result is the value for time, determined 
correct to jr Isec. Precision is therefore to within approx. 
0.5%. The applied pressure is read from the recorder chart 
within 0.2mm giving a precision of approx. 5%
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The least reliable component is the value for weight of fluid, 
determined on the balance scale whose smallest division is Img. 
Precision here is certainly to within O.Smg, ie 17%, of the 
normal control outflow (values under drug treatment always being 
higher than this).
(b) The relationship between lOP, total facility of outflow
(c), episcleral venous pressure (EVP) and the rate of formation 
of aqueous humour (F) are given by the following equation
F
lOP = + EVP
F = (IOP-EVP)C
Most workers assume that EVP is relatively constant and has 
a value in rabbit of approx. 9mm^^. Assuming this to be true in 
the present experiments, values for F can be deduced for any of 
the data shown in the Results section, e.g. in Fig 9 using zero 
time data for the vehicle treated eye.
F = (18.2-9) 0.25
= 2. 3^1m in ^
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